Other systemic involvement of connective tissue (FG)

OTHER_SYSTCON_FG

connective tissue disease: A disorder characterized by abnormalities in one or more of the elements of the connective tissues, typically associated with genetic defects.

Suggest a new description

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters None 0 out of 7 registries used, show all original rules.	0
4. Check minimum number of events None	0
5. Include endpoints M13_SJOGREN M13_OVERLAP M13_BEHCET M13_POLYMYALGIA M13_HYPERMOBILITY M13_CONNECTNAS	12390
6. Filter based on genotype QC (FinnGen only)	12390

Control definitions (FinnGen only)

Control exclude: RHEUMA_ENDPOINTS

Extra metadata

First used in FinnGen datafreeze: DF2

NAME	OTHER_SYSTCON_FG
CONTROL_EXCLUDE	RHEUMA_ENDPOINTS
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	M13_SJOGREN\|M13_OVERLAP\|M13_BEHCET\|M13_POLYMYALGIA\|M13_HYPERMOBILITY\|M13_CONNECTNAS
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Other systemic involvement of connective tissue (FG) based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	84998	63336	21040
Only index persons	72546	55147	17399
Unadjusted period prevalence (%)
Whole population	1.50	1.81	0.59
Only index persons	1.70	2.03	0.66
Median age at first event (years)
Whole population	63.94	62.38	68.54
Only index persons	61.46	59.58	67.43

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	12390	9204	3186
Unadjusted period prevalence (%)	2.69	3.14	1.40
Median age at first event (years)	58.13	54.71	68.02

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
11034: Matched controls
109677

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

M35.9

ICD-10 Finland

Systemic involvement of connective tissue, unspecified

3290.6

323.0

1753

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

56.3

323.0

3761

997

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

231.9

323.0

383

M35.7

ICD-10 Finland

Hypermobility syndrome

424.3

323.0

1928

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

973.0

323.0

983

N02BE01

ATC

paracetamol; systemic, rectal

2.9

323.0

9665

77575

M25.5

ICD-10 Finland

Pain in joint

3.8

323.0

4228

15399

L88

ICPC

Rheumatoid/seropositive arthritis

74.4

323.0

1034

152

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

161.0

323.0

421

L04AX03

ATC

methotrexate; systemic (immunosuppressants)

36.2

323.0

2601

925

M01AH01

ATC

celecoxib; oral (coxibs)

3.0

323.0

2360

9095

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

615.1

323.0

2801

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

7.6

323.0

1346

1972

M16.1

ICD-10 Finland

Other primary coxarthrosis

23.0

323.0

960

452

M35.3

ICD-10 Finland

Polymyalgia rheumatica

153.1

323.0

4522

495

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

43.6

323.0

2212

627

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

62.5

323.0

635

107

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

31.7

323.0

1613

589

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

395.9

323.0

1055

M79.0

ICD-10 Finland

Rheumatism, unspecified

11.5

323.0

1041

982

P01BA02

ATC

hydroxychloroquine; oral

60.6

323.0

3522

842

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

9.1

323.0

1258

1535

PAW37

NOMESCO Finland

Biopsy of temporal artery

71.4

323.0

396

M06.0

ICD-10 Finland

Seronegative rheumatoid arthritis

182.8

323.0

559

M79.6

ICD-10 Finland

Pain in limb

2.4

323.0

4343

23072

M35.1

ICD-10 Finland

Other overlap syndromes

3111.0

323.0

613

H02AB07

ATC

prednisone; oral

4.1

323.0

2480

7277

A02BC02

ATC

pantoprazole; systemic

2.9

323.0

7967

51683

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

2.3

323.0

5058

29822

M05BA04

ATC

alendronic acid; oral

4.3

323.0

1728

4577

M32.9

ICD-10 Finland

Systemic lupus erythematosus, unspecified

584.7

323.0

453

N02AX02

ATC

tramadol; systemic, rectal

2.8

323.0

5090

26020

N03AX12

ATC

gabapentin; oral

3.5

323.0

2196

7267

H02AB06

ATC

prednisolone; systemic

7.8

323.0

8312

30944

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

4.0

323.0

1955

5551

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

22.4

323.0

575

269

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

2.5

323.0

5625

32660

N03AX16

ATC

pregabalin; oral

3.1

323.0

3267

13078

M01AH05

ATC

etoricoxib; oral

2.4

323.0

6382

40010

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

4.2

323.0

5870

23509

H04.10

ICD-10 Finland

Dry eye syndrome

3.6

323.0

1670

5177

L04AA13

ATC

leflunomide; oral

155.6

323.0

508

NFB30

NOMESCO Finland

Primary total prosthetic replacement of hip joint not using cement

83.8

323.0

468

L01BA01

ATC

methotrexate; systemic (folic acid analog.)

61.8

323.0

851

148

M16.0

ICD-10 Finland

Primary coxarthrosis, bilateral

18.2

323.0

545

312

L04AX01

ATC

azathioprine; systemic

9.4

323.0

995

1145

M17.1

ICD-10 Finland

Other primary gonarthrosis

14.0

323.0

2108

1816

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.7

323.0

5421

28954

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

5.9

323.0

1438

2721

M31.5

ICD-10 Finland

Giant cell arteritis with polymyalgia rheumatica

322.9

323.0

463

M05.9

ICD-10 Finland

Seropositive rheumatoid arthritis, unspecified

973.7

323.0

379

A07EC01

ATC

sulfasalazine; oral, rectal

17.2

323.0

1291

837

M13.9

ICD-10 Finland

Arthritis, unspecified

19.4

323.0

1334

771

M79.7

ICD-10 Finland

Fibromyalgia

14.9

323.0

891

643

M06.9

ICD-10 Finland

Rheumatoid arthritis, unspecified

41.9

323.0

621

156

ND2DA

NOMESCO Finland

Bilateral hand X-ray examination

23.9

322.5

470

204

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.4

321.2

3684

19037

H19.3*M35.0

ICD-10 Finland

Keratoconjunctivitis sicca

134.5

317.7

341

N06AX21

ATC

duloxetine; oral

3.5

306.3

1634

5214

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

4.5

306.0

1200

2921

M54.5

ICD-10 Finland

Low back pain

2.3

305.1

3886

21022

NH3DA

NOMESCO Finland

Bilateral foot X-ray examination

18.2

301.5

481

274

M01AC06

ATC

meloxicam; systemic, rectal

2.2

293.5

4200

23881

NF1AA

NOMESCO Finland

Hip X-ray examination

5.2

292.9

983

2027

M79.1

ICD-10 Finland

Myalgia

3.1

290.3

1865

6797

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

4.4

282.7

1123

2759

N02AJ06

ATC

codeine and paracetamol; systemic

2.2

282.2

3911

21813

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

2.1

280.8

4372

25670

R70.0

ICD-10 Finland

Elevated erythrocyte sedimentation rate

10.1

270.5

563

583

R06.0

ICD-10 Finland

Dyspnoea

2.3

265.9

3062

15552

A02BC05

ATC

esomeprazole; systemic

2.1

260.0

4695

29061

NGB40

NOMESCO Finland

Primary total prosthetic replacement of knee joint with patellar part - sliding prosthesis

2430.1

257.4

249

Z96.6

ICD-10 Finland

Presence of orthopaedic joint implants

44.2

255.9

320

A02BC03

ATC

lansoprazole; oral

2.2

248.5

3553

19825

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

2.2

246.8

3316

17986

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

3.5

244.5

1263

3885

M54.4

ICD-10 Finland

Lumbago with sciatica

2.6

238.2

2019

8651

Z01.8

ICD-10 Finland

Other specified special examinations

2.3

235.5

2626

12996

R50.9

ICD-10 Finland

Fever, unspecified

2.7

233.3

1809

7346

XX9XE

NOMESCO Finland

Other ultrasound examination

40.3

229.1

292

B01AB05

ATC

enoxaparin; parenteral

2.2

229.1

3075

16560

SBA10

NOMESCO Finland

Measurement of excretion of saliva

16.2

227.5

378

239

L15

ICPC

Knee symptom/complaint

2.5

227.4

2086

9312

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

3.4

226.3

1241

3985

N06AA09

ATC

amitriptyline; systemic

3.0

220.6

1428

5157

NH3EA

NOMESCO Finland

Feet X-ray examination with load

15.4

219.7

373

249

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

3.7

216.2

1020

2899

J01DB01

ATC

cefalexin; oral

2.1

216.0

8763

71429

M45

ICD-10 Finland

Ankylosing spondylitis

61.5

215.4

254

M35.8

ICD-10 Finland

Other specified systemic involvement of connective tissue

2007.4

214.6

208

UJF32

NOMESCO Finland

Coloscopy

2.1

213.8

3030

16617

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.0

211.1

4092

25414

L28

ICPC

Limited function/disability (L)

2.5

209.7

1885

8282

A02BC01

ATC

omeprazole; systemic

2.1

209.6

3262

18576

T84.0

ICD-10 Finland

Mechanical complication of internal joint prosthesis

24.8

205.4

295

121

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.4

203.8

1941

8787

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

4.8

202.6

717

1549

M07.3*L40.5

ICD-10 Finland

Other psoriatic arthropathies

116.3

200.4

218

7151F

ICD-9 Finland

Osteo-arthrosis and allied disorders, Osteo-arthrosis, localised, primary[OSTEOARTHROSIS PRIMARIA, POLVI]

+∞

198.0

190

M75.1

ICD-10 Finland

Rotator cuff syndrome

2.2

197.6

2502

12982

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

3.4

197.4

1042

3233

M01AX05

ATC

glucosamine; oral

2.4

196.0

2024

9531

TEA00

NOMESCO Finland

Biopsy of lip

15.4

195.6

331

219

R03AC02

ATC

salbutamol; inhalant

1.8

194.6

5699

40535

R51.80

ICD-10 Finland

Headache

2.5

193.6

1820

8160

S18

ICPC

Laceration/cut

1.9

192.4

4308

27924

M01AE02

ATC

naproxen; oral, rectal

1.8

191.8

5979

43326

L13

ICPC

Hip symptom/complaint

2.5

191.2

1678

7243

M01CB01

ATC

sodium aurothiomalate; parenteral

110.9

190.3

208

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

4.3

188.2

749

1819

H02AB04

ATC

methylprednisolone; systemic

2.4

184.0

1790

8147

M70.6

ICD-10 Finland

Trochanteric bursitis

2.6

183.4

1533

6427

L04AB01

ATC

etanercept; parenteral

132.9

183.4

197

WX111

NOMESCO Finland

Local infiltration anesthesia

97.9

183.3

203

I73.0

ICD-10 Finland

Raynaud syndrome

9.0

183.2

404

461

M01AH02

ATC

rofecoxib; oral

2.6

183.0

1542

6495

NGF25

NOMESCO Finland

Operation for osteochondritis of knee, arthroscopic

5.9

182.8

539

941

NFB40

NOMESCO Finland

Primary total prosthetic replacement of hip joint using hybrid technique

24.7

180.8

260

107

TND11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in joint, wrist or hand

56.1

180.6

216

M03BX02

ATC

tizanidine; oral

1.8

179.8

6428

48217

A01

ICPC

Pain general/multiple sites

3.1

178.1

1063

3600

7140A

ICD-9 Finland

Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis[ARTHRITIS RHEUMATOIDES SEROPOSITIVA]

+∞

172.9

166

C03CA01

ATC

furosemide; systemic

1.9

172.5

3159

18865

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

2.5

171.2

1567

6888

M01AB05

ATC

diclofenac; systemic, rectal

1.8

171.1

6819

52512

J45.9

ICD-10 Finland

Asthma, unspecified

2.2

170.3

2073

10473

J01FF01

ATC

clindamycin; systemic

2.0

170.2

2881

16690

C08CA05

ATC

nifedipine; systemic

3.2

168.6

974

3218

L03

ICPC

Low back symptom/complaint

2.0

168.5

2669

15058

M48.0

ICD-10 Finland

Spinal stenosis

2.6

166.5

1327

5392

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

2.1

165.7

2327

12486

E0000UV

ATC

1.8

165.5

4333

29154

J01AA02

ATC

doxycycline; systemic

1.8

165.2

8373

69185

NG1DA

NOMESCO Finland

X-ray of knees

28.0

165.0

229

XPX04

NOMESCO Finland

Angioscopy

43.9

163.2

204

M34.1

ICD-10 Finland

CR(E)ST syndrome

1647.3

162.4

158

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.6

160.9

1297

5299

WX320

NOMESCO Finland

Spinalanesthesy

2.2

159.6

2014

10305

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.9

159.6

3017

18127

M01AX17

ATC

nimesulide; oral

2.0

159.5

2629

15011

Q79.6

ICD-10 Finland

Ehlers-Danlos syndrome

54.9

158.4

190

M01AE03

ATC

ketoprofen; systemic, rectal

1.8

157.8

3976

26307

J01MA02

ATC

ciprofloxacin; systemic

1.8

155.5

4072

27239

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.0

154.6

2557

14588

NF1DA

NOMESCO Finland

X-ray of hips

18.9

154.6

242

130

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

3.2

153.6

879

2875

TNG10

NOMESCO Finland

Puncture of knee

119.6

153.1

166

M34.9

ICD-10 Finland

Systemic sclerosis, unspecified

+∞

153.1

147

TNX00

NOMESCO Finland

Puncture and needle biopsy of soft tissue, unspecified region

9.9

152.7

319

330

R07.4

ICD-10 Finland

Chest pain, unspecified

1.9

150.6

2914

17581

L20

ICPC

Joint symptom/complaint NOS

4.8

149.9

526

1120

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

3.8

149.9

680

1852

G56.0

ICD-10 Finland

Carpal tunnel syndrome

2.4

148.1

1455

6595

B01AF01

ATC

rivaroxaban; oral

2.9

147.6

995

3637

M54.9

ICD-10 Finland

Dorsalgia, unspecified

2.5

147.4

1298

5555

M05BA07

ATC

risedronic acid; oral

4.2

146.7

596

1469

TNG11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in knee

172.4

146.5

154

L17

ICPC

Foot/toe symptom/complaint

1.9

146.4

2666

15714

ZX140

NOMESCO Finland

Intra articular

44.8

146.3

182

M46.9

ICD-10 Finland

Inflammatory spondylopathy, unspecified

217.3

145.9

151

R4120

NOMESCO Finland

Occupational therapy

3.2

144.6

828

2707

J02AC01

ATC

fluconazole; systemic

1.7

144.0

4602

32471

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

3.3

142.1

778

2461

M35.5

ICD-10 Finland

Multifocal fibrosclerosis

110.9

141.0

154

J01FA06

ATC

roxithromycin; oral

1.7

140.3

4338

30238

M15.0

ICD-10 Finland

Primary generalized (osteo)arthrosis

5.9

139.3

410

712

M03BC01

ATC

orphenadrine (citrate); systemic

1.9

138.9

2399

13824

SPAT1153

SPAT

Removal of sutures

1.8

138.7

3174

20156

N02AA05

ATC

oxycodone; systemic

2.3

138.6

1526

7292

L30.9

ICD-10 Finland

Dermatitis, unspecified

2.1

138.6

1951

10386

M02AA07

ATC

piroxicam; topical

1.7

138.1

3872

26184

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.3

137.1

1481

7008

M13.0

ICD-10 Finland

Polyarthritis, unspecified

25.3

136.8

195

R53

ICD-10 Finland

Malaise and fatigue

1.9

136.1

2365

13644

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

2.0

135.1

1925

10285

NE1AA

NOMESCO Finland

Pelvis X-ray examination

3.6

135.0

658

1899

R06AE07

ATC

cetirizine; oral

1.7

134.9

4635

33177

TNH11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in ankle joint or foot joint

70.8

134.5

155

ZXA00

NOMESCO Finland

Right side

1.8

133.6

2714

16525

G44.2

ICD-10 Finland

Tension-type headache

2.2

133.0

1567

7714

L90

ICPC

Osteoarthrosis of knee

4.6

132.6

485

1077

R52.9

ICD-10 Finland

Pain, unspecified

2.6

132.0

1029

4098

A06AC01

ATC

ispaghula (psylla seeds); oral

1.8

132.0

2774

17076

J01DA01

ATC

[U] cefalexin; systemic

1.6

131.7

6585

52049

A02BA02

ATC

ranitidine; systemic

1.9

131.6

2255

12920

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.6

131.1

1050

4247

NGD05

NOMESCO Finland

Partial excision of meniscus of knee, arthroscopic

2.9

130.5

857

3071

SAA03

NOMESCO Finland

Extended examination of mouth

1.7

129.2

3831

26199

L99

ICPC

Musculoskeletal disease other

6.7

128.7

342

519

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

3.5

128.5

644

1900

ZX120

NOMESCO Finland

Intravenous

2.5

127.9

1131

4827

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

7.5

127.8

315

429

L08

ICPC

Shoulder symptom/complaint

2.0

127.5

1957

10742

M10.9

ICD-10 Finland

Gout, unspecified

4.8

127.3

447

951

SPAT1263

SPAT

Sampling

1.6

126.0

4454

31933

M19.0

ICD-10 Finland

Primary arthrosis of other joints

2.7

125.9

954

3731

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.4

125.0

1163

5098

M01CB03

ATC

auranofin; oral

63.9

124.8

146

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.0

124.0

1920

10560

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

7.7

122.6

297

394

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.9

122.3

2324

13767

L04AB04

ATC

adalimumab; parenteral

15.7

122.0

204

131

WX110

NOMESCO Finland

Local anesthesy

1.6

121.8

6869

55436

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

4.7

121.1

438

961

NA1EA

NOMESCO Finland

Cervical spine X-ray examination with flexion

11.0

120.9

238

220

WX002

NOMESCO Finland

Sedation and analgesia

1.9

120.5

1961

10975

TPH04

NOMESCO Finland

Cathetrisation of vein

1.9

120.4

2119

12206

M01AB55

ATC

diclofenac, combinations; oral

2.9

120.1

811

2954

M09AX01

ATC

hyaluronic acid; parenteral

4.9

120.0

411

851

M32.8

ICD-10 Finland

Other forms of systemic lupus erythematosus

+∞

119.7

115

ND2BA

NOMESCO Finland

Hand and fingers extensive X-ray examination

7.6

118.7

289

386

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.6

118.7

4216

30112

SPAT1229

SPAT

Assessment of need for aid

2.6

118.6

926

3682

J01FA10

ATC

azithromycin; systemic

1.6

118.5

5885

45818

Z01.0

ICD-10 Finland

Examination of eyes and vision

2.0

118.3

1790

9737

SAA02

NOMESCO Finland

Basic examination of mouth

1.6

118.1

6240

49331

SAA01

NOMESCO Finland

Simple examination of mouth

1.6

117.5

6963

56632

XCW99

NOMESCO Finland

Other investigative procedure of eye

2.2

117.3

1332

6420

J01CA04

ATC

amoxicillin; systemic

1.7

117.3

8336

71130

C07AB07

ATC

bisoprolol; oral

1.6

117.3

4833

35853

L04AA06

ATC

mycophenolic acid; systemic

7.8

116.3

278

361

WZA90

NOMESCO Finland

Other doctors statement

1.9

116.2

2186

12868

J01MA12

ATC

levofloxacin; systemic

1.9

115.7

1902

10667

M06.8

ICD-10 Finland

Other specified rheumatoid arthritis

92.0

114.9

128

G47.3

ICD-10 Finland

Sleep apnoea

1.9

113.9

1824

10126

D07AC01

ATC

betamethasone; topical

1.7

113.6

3442

23461

R4110

NOMESCO Finland

Physiotherapy

1.8

113.2

2625

16530

ELA30

NOMESCO Finland

Biopsy of salivary gland

38.2

112.2

144

M16.9

ICD-10 Finland

Coxarthrosis, unspecified

4.8

111.1

394

846

ZXA05

NOMESCO Finland

Left side

1.8

109.9

2495

15588

B01AX06

ATC

[U] rivaroxaban; oral

22.4

109.8

162

7250A

ICD-9 Finland

Polymyalgia rheumatica[POLYMYALGIA RHEUMATICA]

+∞

109.3

105

X59

ICD-10 Finland

Exposure to unspecified factor

1.9

108.5

1726

9538

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.9

108.4

1871

10655

M02.9

ICD-10 Finland

Reactive arthropathy, unspecified

19.6

108.3

167

Z01.2

ICD-10 Finland

Dental examination

1.6

107.6

3974

28456

N06AX11

ATC

mirtazapine; oral

1.7

107.2

3305

22550

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.7

106.8

3230

21920

NG1AE

NOMESCO Finland

Knee joint ultrasound exmination

23.3

106.4

155

R42

ICD-10 Finland

Dizziness and giddiness

1.8

106.3

2368

14678

L01

ICPC

Neck symptom/complaint

2.0

105.3

1503

7957

M80.4

ICD-10 Finland

Drug-induced osteoporosis with pathological fracture

184.0

105.3

110

212

Kela drug reimbursment

Gout

+∞

105.1

101

R52.2

ICD-10 Finland

Other chronic pain

3.9

104.9

454

1181

M05BX04

ATC

denosumab; parenteral

2.9

104.7

673

2369

N06CA01

ATC

amitriptyline and psycholeptics; systemic

2.2

103.8

1200

5811

N06AX16

ATC

venlafaxine; oral

2.0

103.7

1456

7653

M03BC51

ATC

orphenadrine, combinations; systemic

1.7

103.5

2839

18710

M07.3

ICD-10 Finland

Other psoriatic arthropathies

180.6

103.2

108

M35.2

ICD-10 Finland

Behçet disease

+∞

103.0

G73.7*M35.0

ICD-10 Finland

Myopathy in sicca syndrome [Sjögren]

+∞

103.0

L18

ICPC

Muscle pain

3.5

103.0

519

1533

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

2.3

102.9

1085

5034

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.5

102.4

5310

41142

NG2AA

NOMESCO Finland

Patella X-ray examination

9.3

102.3

219

237

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

1.6

102.3

3708

26329

K07.60

ICD-10 Finland

Snapping jaw

3.0

101.9

624

2123

SPAT1249

SPAT

Treatment-related counselling outside office

1.6

101.9

4093

29816

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.5

101.7

5014

38371

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.1

101.6

1318

6700

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.8

100.8

2275

14127

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

4.2

100.2

401

971

R60.0

ICD-10 Finland

Localized oedema

2.2

100.0

1136

5452

M32.0

ICD-10 Finland

Drug-induced systemic lupus erythematosus

+∞

99.9

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.5

99.7

5106

39351

R03DC03

ATC

montelukast; oral

1.9

99.4

1677

9440

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.9

99.0

1699

9622

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

4.1

98.9

404

997

M05

ICD-10 Finland

Seropositive rheumatoid arthritis

132.9

98.9

106

A07AA02

ATC

nystatin; oral

2.6

98.9

788

3157

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

2.8

98.4

667

2426

SPAT1301

SPAT

No procedures

1.6

98.1

3268

22643

Z71.8

ICD-10 Finland

Other specified counselling

1.7

97.5

2403

15301

R01AD09

ATC

mometasone; nasal

1.5

97.5

4486

33655

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.6

97.2

794

3224

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

2.6

96.6

789

3206

L12

ICPC

Hand/finger symptom/complaint

2.0

96.3

1433

7691

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.8

96.0

1993

12028

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

2.2

95.9

1046

4921

L89

ICPC

Osteoarthrosis of hip

7.0

95.8

246

356

P01AB01

ATC

metronidazole; oral, rectal

1.6

94.5

4122

30461

M53.1

ICD-10 Finland

Cervicobrachial syndrome

2.1

94.5

1142

5624

M46.1

ICD-10 Finland

Sacroiliitis, not elsewhere classified

22.0

94.5

140

M01AX01

ATC

nabumetone; oral

3.3

94.4

519

1637

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.0

94.4

1335

7018

NFB50

NOMESCO Finland

Primary total prosthetic replacement of hip joint using cement

28.8

94.1

129

M04AA01

ATC

allopurinol; systemic

2.2

93.2

993

4619

Z50.1

ICD-10 Finland

Other physical therapy

2.9

93.1

608

2159

WZA10

NOMESCO Finland

Long statement of health and health related matters

8.1

92.4

215

268

S01XA18

ATC

ciclosporin; ophthalmic

12.6

92.2

169

135

L40.5

ICD-10 Finland

Arthropathic psoriasis

18.6

91.9

144

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.8

91.5

1701

9879

NA6BG

NOMESCO Finland

Sacro-iliac joint MRI examination with high intensity magnet

8.8

91.5

202

231

R01AD08

ATC

fluticasone; nasal

1.6

91.4

2809

18975

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.6

91.0

3236

22700

7102B

ICD-9 Finland

Diffuse diseases of connective tissue, Sicca syndrome[SYNDROMA SICCUM SECUNDARIUM]

+∞

90.5

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

3.4

90.4

459

1363

M54.6

ICD-10 Finland

Pain in thoracic spine

2.5

90.4

741

3015

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.6

90.0

717

2868

M01AE01

ATC

ibuprofen; systemic, rectal

1.7

89.9

9111

81275

D64.9

ICD-10 Finland

Anaemia, unspecified

2.2

89.4

1052

5114

A01AB09

ATC

miconazole; local oral

2.1

89.3

1063

5196

M47.82

ICD-10 Finland

Other spondylosis, cervical region

3.5

89.2

449

1324

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.9

88.6

1591

9118

M32.1

ICD-10 Finland

Systemic lupus erythematosus with organ or system involvement

+∞

88.4

XG410

NOMESCO Finland

Flow-volume spirometry

3.2

88.4

490

1554

R05

ICD-10 Finland

Cough

1.7

88.1

1967

12106

NGA30

NOMESCO Finland

Exploration of knee joint, arthroscopic

3.9

87.9

378

977

H03AA01

ATC

levothyroxine sodium; systemic

1.6

87.3

2674

18010

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

2.1

87.0

1038

5075

TNB11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in shoulder joint

42.0

86.8

109

M54.2

ICD-10 Finland

Cervicalgia

2.4

86.6

767

3250

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.9

86.4

1372

7521

73491

ICD-8 Finland

Diffuse diseases of connective tissue, Collagenosis NUD

+∞

86.3

K02.1

ICD-10 Finland

Caries of dentine

1.5

85.7

5310

42128

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.6

85.7

2907

20087

N05CF01

ATC

zopiclone; oral

1.6

84.9

3328

23813

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.5

84.8

4591

35349

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.1

84.5

1042

5164

WZC10

NOMESCO Finland

Extensive specialist consultion with written report

2.9

84.0

554

1978

SHB00

NOMESCO Finland

Prepation and fitting of bite rail to mouth

2.1

83.9

989

4806

A46

ICD-10 Finland

Erysipelas

2.0

83.7

1224

6499

NG1EA

NOMESCO Finland

Knee X-ray examination with wrench

20.3

83.6

127

S01GX01

ATC

cromoglicic acid; ophthalmic

1.7

83.6

2059

13025

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

4.7

83.3

297

641

7109X

ICD-9 Finland

Diffuse diseases of connective tissue, Unspecified diffuse connective tissue disease

+∞

83.2

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.1

82.9

1023

5070

M80.0

ICD-10 Finland

Postmenopausal osteoporosis with pathological fracture

7.5

82.7

203

275

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.9

82.5

1387

7750

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.0

81.9

1224

6552

ACC51

NOMESCO Finland

Release of median nerve

2.4

81.7

723

3061

J45.0

ICD-10 Finland

Predominantly allergic asthma

2.2

81.7

885

4138

J01MA14

ATC

moxifloxacin; systemic

2.2

81.5

917

4363

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.2

81.5

909

4305

L04AA01

ATC

[U] ciclosporin; systemic

7.7

80.7

194

255

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

2.0

80.6

1099

5670

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

2.3

80.2

833

3817

M81.9

ICD-10 Finland

Osteoporosis, unspecified

2.9

79.7

524

1866

SPAT1216

SPAT

Assessment of functional ability

1.8

79.6

1542

9040

NFC20

NOMESCO Finland

Secondary implantation of hip prosthesis

22.8

79.4

116

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.9

79.3

517

1830

XQ841

NOMESCO Finland

Examination of dermatosis with microscope

50.6

79.3

M17.5

ICD-10 Finland

Other secondary gonarthrosis

23.1

79.0

115

SPAT1202

SPAT

Intra-articular injection

4.1

78.9

321

789

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.9

78.9

1261

6914

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

2.1

78.8

1034

5250

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

2.6

78.5

610

2401

R02

ICPC

Shortness of breath/dyspnoea

1.9

78.2

1220

6627

UJF30

NOMESCO Finland

Ileoscopy through colon

2.1

78.2

974

4841

SHA03

NOMESCO Finland

Correction of physiology of bite - demanding therapy visit

3.4

77.9

395

1171

AA1AD

NOMESCO Finland

CT of head and brain

1.6

77.6

2311

15370

L04AD01

ATC

ciclosporin; systemic

5.9

77.5

225

384

NF1BA

NOMESCO Finland

Hip extensive X-ray examination

5.2

76.5

246

475

M33.2

ICD-10 Finland

Polymyositis

260.8

76.3

E000001

ATC

1.7

76.2

2047

13229

M06

ICD-10 Finland

Other rheumatoid arthritis

78.4

75.9

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

3.1

75.9

447

1478

M02AA10

ATC

ketoprofen; topical

1.8

75.9

1563

9335

NGF35

NOMESCO Finland

Plastic operation of joint cartilage of knee

5.4

75.5

236

441

R03BA05

ATC

fluticasone; inhalant

1.7

75.2

1794

11204

J01FA09

ATC

clarithromycin; systemic

1.5

75.0

3073

22075

7100A

ICD-9 Finland

Diffuse diseases of connective tissue, Systemic lupus erythematosus

+∞

74.9

SPAT1310

SPAT

Counselling related to known health issue

1.5

74.5

3141

22703

SHA02

NOMESCO Finland

Correction of physiology of bite - basic therapy visit

2.3

74.4

714

3147

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.3

74.4

773

3539

K11.2

ICD-10 Finland

Sialoadenitis

3.3

74.2

405

1269

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.2

74.2

811

3801

C08CA01

ATC

amlodipine; oral

1.5

74.1

3373

24795

SPAT1254

SPAT

Administration of medicine

1.8

74.1

1477

8724

J05AB01

ATC

aciclovir; systemic

1.6

74.0

2159

14253

A28

ICPC

Limited function/disability NOS

1.8

73.3

1469

8688

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.2

73.0

772

3565

T84.5

ICD-10 Finland

Infection and inflammatory reaction due to internal joint prosthesis

17.6

72.9

116

N06AB04

ATC

citalopram; systemic

1.6

72.8

2231

14911

R05

ICPC

Cough

1.6

72.7

2171

14411

M17.3

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3000850) Epithelial cells [#/volume] in Urine

3624

19379

2.21

317.54

3.1

2.4

e6/l

5.1

6.7

10.28

3259

16650

(3002582) Erythrocytes [#/volume] in Urine

4771

28387

2.09

316.67

4.0

3.0

e6/l

58.4

99.8

1.57

3961

21152

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

1505

5364

3.03

309.29

1.3

au/ml

38.3

47.4

0.60

239

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

2561

11942

2.42

308.85

2.6

2.4

21.3

22.4

3.67

2196

10146

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

596

458

13.53

307.65

1.5

1.1

u/ml

62.0

32.1

1.41

118

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

595

457

13.53

307.65

1.5

1.1

u/ml

90.1

89.1

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

579

433

13.88

307.65

1.5

1.1

u/ml

15.9

3.0

2.68

(3037467) Urinalysis macro (dipstick) panel - Urine

9773

66494

3.18

307.65

7.0

3.9

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

5150

13477

5.78

307.65

1.5

1.2

iu/ml

48.6

18.7

10.10

1918

3711

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

4698

26413

2.23

307.65

3.4

2.8

ng/l

1239.7

1442.2

3.44

4097

22471

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

702

1009

7.27

307.65

1.4

1.1

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

7963

48284

2.79

307.65

7.0

6.0

mmol/l

1.2

7.38

6831

40235

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

644

415

16.20

307.65

1.3

1.1

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1789

1270

16.18

307.65

1.5

1.1

u/ml

3.0

3.9

0.16

260

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1209

2984

4.35

307.65

1.7

2.4

g/l

7.7

7.3

9.59

900

2166

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1124

2793

4.30

307.65

1.7

2.5

g/l

10.8

10.2

2.90

954

2282

(3022096) Basophils/100 leukocytes in Blood

8073

40393

3.83

307.65

10.0

4.6

0.7

0.59

7749

37039

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

1053

1529

7.38

307.65

1.6

iu/ml

4.6

10.8

0.30

238

330

(3019198) Lymphocytes [#/volume] in Blood

9023

45667

4.54

307.65

9.7

4.5

e9/l

1.8

2.0

16.16

8403

39361

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

644

414

16.24

307.65

1.3

1.1

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

1728

3022

6.44

307.65

1.6

1.2

u/ml

20.2

3.3

3.73

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

6231

27684

3.49

307.65

2.7

2.0

u/l

124.9

202.4

18.22

5897

25747

(3005719) IgG [Mass/volume] in Serum or Plasma

2406

5689

4.97

307.65

3.3

2.6

g/l

11.3

10.5

9.37

2249

5155

(3013650) Neutrophils [#/volume] in Blood by Automated count

9445

53080

4.23

307.65

11.9

8.0

e9/l

4.2

4.1

4.22

8726

45486

(3018010) Neutrophils/100 leukocytes in Blood

8199

42620

3.69

307.65

9.8

4.5

58.5

57.2

20.41

7860

39268

(3002179) Metamyelocytes/100 leukocytes in Blood

1936

6146

3.52

307.65

5.1

3.5

0.4

0.7

7.12

436

1390

(3022948) Iron [Moles/volume] in Serum or Plasma

2928

14033

2.40

307.65

2.5

2.3

umol/l

12.3

13.1

8.52

2706

12854

(3013115) Eosinophils [#/volume] in Blood

9087

46089

4.60

307.65

9.9

4.7

e9/l

0.2

24.78

8448

39568

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

2102

1599

15.52

307.65

1.6

1.1

u/ml

7.8

3.6

1.73

491

(3015171) Extractable nuclear Ab [Units/volume] in Serum

2475

2650

11.34

307.65

1.5

1.2

u/ml

2.3

0.5

4.65

241

227

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

641

409

16.36

307.65

1.3

1.1

—

(40760892) CBC W Ordered Manual Differential panel - Blood

4296

19228

2.87

307.65

6.9

3.6

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1206

2977

4.35

307.65

1.7

2.4

g/l

3.8

0.23

875

2063

(3018095) Leukocytes [#/volume] in Urine

5595

33512

2.20

307.65

4.9

3.4

e6/l

69.3

123.7

8.59

4227

22964

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

1657

5900

3.07

307.65

2.5

2.3

au/ml

29.8

25.3

0.44

356

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

343

209

16.74

307.65

1.7

1.1

36.8

28.8

1.53

211

106

(3004588) Protein electrophoresis panel - Serum or Plasma

2183

5223

4.83

307.65

1.9

2.5

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

2163

8182

2.97

307.65

2.0

2.2

nmol/l

350.8

390.0

11.85

2014

7469

(3004616) Nuclear Ab [Presence] in Serum

845

779

11.49

307.65

1.6

1.2

—

(3013707) Erythrocyte sedimentation rate by Westergren method

10777

69680

5.12

307.65

10.3

3.0

mm/h

14.9

12.2

62.10

10380

63172

(3038026) Centromere Ab [Units/volume] in Serum

627

466

14.02

307.65

1.5

1.1

u/ml

35.4

43.7

0.16

(3021589) Normoblasts [#/volume] in Blood

6579

41185

2.25

307.65

14.0

8.1

e9/l

0.0

0.13

5737

32967

(3001604) Monocytes [#/volume] in Blood

8932

44133

4.62

307.65

9.6

4.4

e9/l

0.6

0.63

8233

37193

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1207

2980

4.35

307.65

1.7

2.4

—

(3023420) DNA double strand Ab [Units/volume] in Serum

770

462

17.58

307.65

2.4

1.1

iu/ml

34.8

18.7

—

(3021788) Differential panel - Synovial fluid

552

348

16.44

307.65

1.6

1.1

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

813

677

12.69

307.65

1.6

1.1

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

942

2199

4.52

307.65

1.8

2.5

g/l

0.0

0.1

2.43

854

1974

(3000475) Leukocytes [#/volume] in Synovial fluid

767

545

14.83

307.65

1.9

1.2

e6/l

12809.3

13217.3

0.05

610

374

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

7320

40399

2.95

307.65

2.8

2.1

nmol/l

81.0

2369.7

0.50

6778

35789

(3001122) Ferritin [Mass/volume] in Serum or Plasma

6462

42416

2.07

307.65

3.5

2.7

ug/l

125.7

115.1

1.58

5982

39005

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

4990

12405

6.02

307.65

1.4

1.2

u/ml

14.5

2.8

11.94

2006

4635

(3008898) HLA-B27 [Presence]

951

2187

4.59

307.65

1.1

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

4448

23457

2.38

307.65

2.7

2.1

mg/l

3.0

2.9

1.10

3853

19702

(3017181) Myelocytes/100 leukocytes in Blood

2139

6793

3.57

307.65

5.5

3.6

0.8

1.0

1.82

610

1924

(3035350) Ketones [Presence] in Urine by Test strip

7526

46598

2.54

307.65

5.4

3.4

estimate

0.0

1.08

1683

8290

(3024980) IgG subclass 4 [Mass/volume] in Serum

663

1196

5.76

307.65

2.0

1.4

g/l

0.7

0.06

503

891

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

421

255

16.94

307.65

1.2

1.0

—

(3020630) Protein [Mass/volume] in Serum or Plasma

2364

6704

4.09

307.65

2.0

2.7

g/l

67.4

66.1

11.81

2140

6013

(3013293) Extractable nuclear Ab [Presence] in Serum

320

72.48

307.65

1.7

1.3

—

(3021440) Promyelocytes/100 leukocytes in Blood

2046

6463

3.57

307.65

5.6

3.6

0.1

0.2

3.72

566

1796

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

430

233

18.95

307.65

1.7

1.1

50.7

60.9

2.14

268

109

(3024561) Albumin [Mass/volume] in Serum or Plasma

6441

41524

2.13

307.65

4.8

4.4

g/l

35.0

35.4

7.20

5992

38149

(3018418) pH of Serum or Plasma

5059

28733

2.27

307.65

4.1

3.7

7.4

0.07

964

5319

(3007164) IgA [Mass/volume] in Serum or Plasma

3752

17801

2.57

307.65

1.7

1.4

g/l

2.5

2.3

3.62

2537

10263

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

1361

2395

6.22

307.65

1.8

1.4

titre

444.9

209.9

1.76

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

2193

1852

14.08

307.65

1.6

1.1

u/ml

48.2

19.2

4.82

353

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1625

1291

14.24

307.65

1.5

1.1

u/ml

13.8

0.4

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

1223

3414

3.84

307.65

1.7

2.0

u/l

38.0

39.6

1.88

1097

3001

(40759836) Histone Ab [Presence] in Serum by Immunoblot

641

409

16.36

307.65

1.3

1.1

—

(42870588) Differential panel, method unspecified - Blood

6498

29591

3.48

307.65

8.9

4.7

—

(3019069) Monocytes/100 leukocytes in Blood

8215

42026

3.79

307.65

10.4

4.8

8.7

8.5

10.90

7893

38761

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

1665

1414

13.36

307.65

1.6

1.1

u/ml

63.9

25.9

11.54

323

110

(3006315) Basophils [#/volume] in Blood

8969

44370

4.65

307.65

9.6

4.4

e9/l

0.0

0.83

8257

37401

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

952

2332

4.31

307.65

1.7

2.4

g/l

36.9

38.0

5.06

808

1941

(3044941) Cell count panel - Synovial fluid

420

344

12.52

307.65

1.6

1.1

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

2313

1929

14.41

307.65

2.6

1.2

g/l

1.1

1.2

9.39

2239

1819

(3023368) Bacteria identified in Blood by Culture

4284

23945

2.19

307.65

5.0

4.0

—

(3025159) Blasts/100 leukocytes in Blood

1949

6066

3.60

307.65

5.7

3.6

0.2

0.3

0.25

492

1525

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

1044

2029

5.49

307.65

1.6

1.2

iu/ml

17.8

5.8

2.25

(3002030) Lymphocytes/100 leukocytes in Blood

8285

43345

3.71

307.65

10.2

4.7

26.9

28.1

18.76

7940

39767

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

7192

43539

2.53

307.65

6.2

5.3

mmol/l

1.2

4.72

6659

38898

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

644

414

16.24

307.65

1.3

1.1

—

(3006504) Eosinophils/100 leukocytes in Blood

8186

41781

3.79

307.65

10.0

4.6

2.6

2.8

21.86

7866

38277

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

641

410

16.32

307.65

1.3

1.1

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

1031

2520

4.34

307.65

1.9

2.6

g/l

0.5

1.1

4.65

893

2114

(3026493) Urate [Moles/volume] in Serum or Plasma

4520

20840

2.82

307.65

2.6

2.3

umol/l

2789.7

5710.6

6.34

3970

17815

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

10551

73943

3.81

307.65

10.5

6.7

u/l

74.1

78.4

22.92

10206

68720

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

2117

1629

15.36

307.65

1.6

1.1

u/ml

14.4

4.2

9.00

704

159

(3021601) Nitrite [Presence] in Urine by Test strip

7494

46904

2.49

307.65

7.2

4.7

estimate

0.0

0.01

1732

8360

(3037522) Nuclear Ab [Titer] in Serum

5124

10037

7.94

307.65

1.8

1.2

titre

980.0

410.7

58.08

1914

1772

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1140

2787

4.37

307.65

1.8

2.5

g/l

3.2

3.0

9.39

890

2111

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

818

1358

6.33

307.65

1.4

1.1

titre

230.9

40.0

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

302

219

14.01

307.65

1.6

1.1

e6/l

33533.9

235539.0

2.27

214

136

(3009261) Glucose [Presence] in Urine by Test strip

7558

47390

2.50

307.65

5.6

3.5

estimate

0.0

2.41

1714

8300

(3028026) IgM [Mass/volume] in Serum or Plasma

1870

4531

4.65

307.65

1.9

g/l

1.4

0.24

1732

4072

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

466

340

14.11

307.65

1.8

1.3

u/l

5.6

6.2

0.40

398

277

(3039162) Centromere protein B Ab [Units/volume] in Serum

1166

760

16.72

307.65

1.6

1.1

u/ml

47.6

40.0

0.25

125

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

2194

1889

13.80

307.65

2.8

1.3

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

2307

1856

14.94

307.65

2.7

1.2

g/l

0.2

47.53

2218

1744

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

842

2063

4.28

306.39

1.8

2.5

g/l

0.0

1.38

758

1845

(3004789) Transferrin [Mass/volume] in Serum or Plasma

2696

12903

2.37

306.34

2.5

2.3

g/l

2.3

2.4

2.44

2501

11780

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

830

2029

4.28

302.86

1.8

2.6

g/l

0.0

0.00

757

1837

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

7175

50140

2.00

296.59

5.8

6.0

umol/l

9.9

11.2

28.57

6807

47288

(4062490)

482

746

6.64

294.31

1.8

1.3

—

(3031040) Bacteria [#/volume] in Urine by Automated count

8780

66046

2.10

293.80

6.3

4.3

e6/l

1588.0

2210.5

0.49

135

921

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

11497

97365

3.40

291.21

25.9

12.2

mg/l

19.7

24.3

53.63

10309

74657

(40758558) Short blood count panel - Blood

4076

23455

2.08

290.50

8.0

6.3

—

(3030467) Casts [#/volume] in Urine by Automated count

4378

26004

2.04

284.91

3.9

2.9

e6/l

0.3

0.5

9.45

3572

19080

(3028192) IgG subclass 2 [Mass/volume] in Serum

474

747

6.51

284.34

1.8

1.2

g/l

2.9

0.24

348

510

(3024139) IgG subclass 3 [Mass/volume] in Serum

473

748

6.49

282.78

1.8

1.3

g/l

0.4

0.68

348

510

(3027135) IgG subclass 1 [Mass/volume] in Serum

473

749

6.48

282.41

1.8

1.2

g/l

7.3

6.6

1.66

345

511

(3011397) Hemoglobin [Presence] in Urine by Test strip

3831

21871

2.07

276.28

5.2

3.4

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

5571

36274

1.95

276.11

6.0

3.6

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

819

2129

4.02

274.57

1.7

2.1

mg/l

10.6

10.8

0.37

755

1974

(3029937) Albumin [Presence] in Urine by Test strip

4240

25162

2.02

274.36

6.3

3.7

estimate

0.0

0.18

1728

8110

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

225

130

17.49

273.77

1.2

1.0

—

(3013637) Mi-2 Ab [Presence] in Serum

225

130

17.49

273.77

1.2

1.0

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

225

130

17.49

273.77

1.2

1.0

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

225

130

17.49

273.77

1.2

1.0

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

879

2418

3.81

272.00

2.3

3.6

mg/l

36.1

49.4

2.14

692

1990

(3037756) Immunofixation for Serum or Plasma

679

1546

4.56

271.00

1.5

1.8

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

875

2423

3.78

268.10

2.3

3.6

mg/l

47.5

76.3

0.66

685

1990

(3013826) Glucose [Moles/volume] in Serum or Plasma

7637

55611

1.95

267.20

5.2

4.3

mmol/l

6.5

6.7

15.82

7263

51492

(36304419) Bacteria [Presence] in Urine

4243

25428

2.00

265.07

3.8

2.9

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

854

2348

3.81

264.31

2.3

3.5

ratio

2.5

5.4

0.45

170

(3042936) Bacteria identified in Isolate by Culture

2309

11005

2.33

260.52

2.2

1.8

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

2151

9983

2.38

257.74

3.2

4.2

u/l

236.6

246.2

2.30

2008

9406

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

5972

40410

1.90

257.69

2.2

1.9

pmol/l

97.9

96.4

1.60

3180

20008

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

945

2853

3.48

253.98

2.1

2.2

ug/l

217.6

642.6

4.37

841

2671

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

4726

29740

1.94

253.18

2.8

2.4

u/l

58.0

59.5

0.71

4369

27198

(3027945) Reticulocytes/100 erythrocytes in Blood

2094

9680

2.38

252.77

2.6

2.4

1.7

1.8

0.95

1860

8465

(3021960) Folate [Moles/volume] in Serum or Plasma

3787

22238

2.00

247.28

1.6

1.5

nmol/l

20.3

20.8

0.96

3278

18776

(3015377) Calcium [Moles/volume] in Serum or Plasma

5178

33969

1.88

240.94

3.0

3.5

mmol/l

2.3

2.4

7.06

4497

29297

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

3643

21274

1.99

240.45

1.4

1.3

u/ml

1.6

1.7

0.38

1022

5635

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

394

615

6.54

238.32

2.2

1.7

mg/l

3.2

4.0

2.75

377

577

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

2735

14601

2.10

229.69

2.1

1.8

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

5332

35816

1.84

225.74

4.6

3.4

ng/l

208.0

46.1

0.96

3724

23703

(40760888) Immunoglobulin light chains.free panel - Serum

679

1790

3.93

222.47

2.3

3.7

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

9645

78325

2.01

217.91

5.0

4.2

pmol/l

14.9

14.8

6.49

8905

70982

(3023520) Reticulocytes [#/volume] in Blood

1606

7019

2.46

217.32

2.4

2.6

e9/l

67.6

69.1

0.95

1215

5256

(3034891) Synovial lining cells/100 cells in Synovial fluid

182

110

16.66

216.46

1.7

1.1

5.2

1.6

2.27

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

362

575

6.41

215.17

1.2

1.1

iu/ml

2.0

2.1

—

(3032080) INR in Blood by Coagulation assay

5408

36855

1.81

215.16

9.8

8.5

inr

1.2

0.75

1696

10656

(3044927) Protein electrophoresis panel - Urine

382

674

5.78

204.01

1.2

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

3388

20219

1.91

203.76

1.9

1.6

mg/l

1.2

0.38

2663

15258

(3017143) Hepatitis C virus Ab [Presence] in Serum

1881

9067

2.25

202.23

1.5

1.6

—

(40768797) Stomach Pathology biopsy report

2439

13083

2.06

198.86

1.3

1.2

—

(3048689) Calprotectin [Mass/mass] in Stool

2173

11238

2.12

195.00

2.2

2.1

ug/g

142.9

129.3

0.81

1723

8576

(3026782) Osmolality of Urine

3148

18564

1.92

194.90

3.5

2.6

mosm/kgh2o

509.5

534.7

9.28

2770

15510

(3019309) Folate [Moles/volume] in Red Blood Cells

3093

18311

1.90

188.22

1.9

1.7

nmol/l

1185.4

1168.2

0.47

2427

13503

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

2778

15911

1.95

186.55

3.2

2.6

e6/l

1.1

1.5

1.48

1817

8775

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

898

3206

2.92

180.53

2.1

1.8

ug/l

1.2

2.3

3.19

774

2806

(3007853) Bacteria identified in Skin by Aerobe culture

1985

10214

2.11

179.16

2.0

1.7

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

10708

92277

2.12

176.98

6.2

4.9

mu/l

1.9

2.1

3.86

10015

84138

(40761535) Cells panel - Urine sediment

1564

7372

2.27

175.82

5.0

3.1

—

(3041096) Erythrocytes [Presence] in Urine by Automated

3908

25309

1.78

175.45

5.1

3.2

—

(3019150) Specific gravity of Urine by Refractometry

3299

20465

1.82

170.24

6.1

3.8

kg/l

1.0

0.88

461

3178

(3026008) Bacteria identified in Urine by Culture

4649

32092

1.70

163.36

3.9

3.1

—

(3017732) Neutrophils [#/volume] in Blood

1313

5921

2.35

163.14

3.3

2.6

e9/l

4.3

4.1

0.87

946

4549

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

465

1183

4.02

159.53

1.4

1.2

u/ml

3.8

4.0

0.11

235

503

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

5783

42668

1.65

154.68

4.6

3.7

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

11353

101289

2.35

153.11

23.1

14.8

mmol/l

139.5

139.6

8.95

11164

98138

(3003458) Phosphate [Moles/volume] in Serum or Plasma

2046

11234

1.97

152.07

4.9

5.1

mmol/l

1.0

0.44

1893

10324

(3023103) Potassium [Moles/volume] in Serum or Plasma

11362

101556

2.34

149.89

23.3

15.0

mmol/l

3.9

4.0

5.13

11161

98176

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1232

5603

2.31

149.50

1.4

—

(3034770) Mitochondria Ab [Titer] in Serum

677

2293

3.04

148.93

1.3

1.2

titre

1006.3

829.8

0.38

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

462

1236

3.82

147.60

1.4

1.2

u/ml

3.9

3.2

0.40

210

390

(3024263) Appearance of Synovial fluid

174

184

9.51

146.49

2.3

1.2

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1385

6674

2.19

145.96

1.8

1.6

—

(3005322) IgE [Units/volume] in Serum or Plasma

1232

5673

2.28

145.00

1.4

1.3

u/ml

182.9

199.8

0.36

1115

5210

(3007566) Smooth muscle Ab [Titer] in Serum

669

2293

3.01

144.05

1.2

titre

133.8

165.0

0.33

200

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1843

9959

1.98

142.67

1.9

1.7

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

10526

91872

1.92

141.97

19.7

12.1

ml/min/173m2

80.2

79.8

0.98

9376

74225

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

4349

30358

1.65

140.96

3.5

3.1

u/l

31.0

34.1

3.35

4149

28674

(3000494) Fungus identified in Specimen by Culture

1882

10308

1.96

139.87

1.6

1.4

—

(4268621)

348

792

4.46

138.24

2.4

2.2

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1823

9973

1.96

135.62

2.0

1.7

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

1382

6889

2.12

132.89

3.2

3.4

ng/l

80.0

87.9

2.52

1192

5815

(3013166) Neutrophils/100 leukocytes in Synovial fluid

111

16.35

130.99

1.6

1.1

47.3

56.7

0.95

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

3188

20851

1.70

130.64

1.8

1.6

pmol/l

35838821.1

29674086.4

0.21

2648

16914

(3007916) DNA double strand Ab [Titer] in Serum

105

18.13

130.30

1.7

1.0

titre

138.0

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

2484

15223

1.78

128.14

1.7

1.9

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

2917

18733

1.71

127.36

2.8

3.1

mmol/l

2.5

0.07

2556

16242

(3012095) Magnesium [Moles/volume] in Serum or Plasma

2443

14943

1.78

126.69

3.1

mmol/l

0.8

0.25

2246

13791

(21491868) Cryoglobulin [Mass/volume] in Serum

190

271

7.06

124.93

1.2

g/l

0.3

0.2

0.17

(3045414) Leukocytes [Presence] in Urine

939

4093

2.38

124.80

2.0

1.8

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

150

162

9.30

124.29

1.8

1.6

ug/l

7.7

9.1

2.57

150

162

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

11492

104456

2.28

124.23

17.2

9.0

u/l

24.4

24.6

1.00

11275

99937

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

2437

15029

1.76

122.32

3.5

2.7

e6/l

3.5

3.6

0.17

1488

7972

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

881

3771

2.42

121.87

2.0

1.7

g/l

1.7

1.5

4.22

761

3189

(3022217) INR in Platelet poor plasma by Coagulation assay

2068

12178

1.82

121.23

24.7

24.2

inr

1.3

1.4

0.69

329

1568

(3013512) EKG study

3911

27412

1.61

120.03

4.5

3.8

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

282

610

4.68

119.30

1.2

titre

373.3

142.1

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

10133

88650

1.74

118.98

6.5

5.5

mmol/mol

39.5

39.6

0.54

9472

80808

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

282

612

4.66

118.83

1.2

titre

262.9

210.7

0.40

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

2146

12868

1.79

118.15

1.5

1.6

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

358

959

3.79

114.02

1.6

1.3

—

(3011412) CD3 cells [#/volume] in Blood

307

738

4.21

113.55

2.3

2.5

e9/l

1.2

0.38

190

429

(3035947) Staphylolysin Ab [Units/volume] in Serum

177

261

6.82

112.86

1.2

1.1

iu/ml

4.5

3.4

0.67

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

690

2810

2.52

105.98

2.8

2.6

—

(3019225) pH of Specimen

1663

9573

1.84

103.59

4.7

3.9

—

(3036670) Protein [Mass/volume] in Synovial fluid

14.68

101.50

1.3

1.1

g/l

38.3

36.4

0.33

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

509

1817

2.86

101.39

1.5

1.7

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

238

524

4.58

98.52

2.2

—

(3036071) Salmonella sp Ab [Titer] in Serum

117

124

9.45

98.33

1.1

—

(3004809) Band form neutrophils/100 leukocytes in Blood

415

1359

3.10

96.37

3.0

3.4

1.1

1.6

2.67

331

1057

(3044640) Blood type and Crossmatch panel - Blood

4037

29632

1.52

95.95

2.6

2.3

—

(3037121) Protein [Mass/volume] in Urine

700

3009

2.39

95.41

2.6

3.0

g/l

0.3

0.06

261

1163

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

7490

62377

1.49

94.64

3.6

2.9

u/l

51.0

44.4

6.47

6938

57636

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

1032

5216

2.05

94.18

4.0

3.3

kpa

5.1

5.2

0.70

949

4810

(3009343) pH of Capillary blood

1020

5147

2.06

93.47

4.0

3.3

7.4

0.25

132

695

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

1383

7766

1.87

92.59

3.1

2.7

ng/l

183.9

201.1

0.82

1253

7106

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

428

1461

2.98

92.42

4.3

5.5

iu/ml

1246.9

975.9

0.17

223

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

992

4979

2.06

92.19

3.9

3.2

mmol/l

1.9

0.06

731

3697

(40761511) CBC panel - Blood by Automated count

11188

102400

1.88

92.04

20.8

12.0

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

1409

8030

1.84

89.81

3.8

3.5

mmol/l

1.2

0.62

1254

6834

(3020779) Urea [Moles/volume] in Serum or Plasma

1322

7403

1.87

89.09

6.1

6.5

mmol/l

9.7

9.5

0.53

1254

7004

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

10558

95258

1.68

88.47

5.1

4.4

mmol/l

5.8

5.9

21.44

9722

86188

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

3136

22182

1.54

86.66

2.6

2.2

—

(1175426) CD3 cells/100 lymphocytes in Blood

239

585

4.12

86.29

2.1

2.2

74.3

72.9

0.63

226

562

(21494815) CD4 cells/100 lymphocytes in Specimen

247

621

4.01

85.99

2.0

2.3

45.7

41.1

0.83

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

223

525

4.28

84.78

2.3

2.6

e6/l

462.3

531.9

1.46

184

437

(36660697) Celiac disease serology panel - Serum

1327

7551

1.83

84.73

1.2

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

1021

5338

1.98

84.41

1.6

1.5

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1480

8722

1.78

84.05

2.3

2.1

g/l

0.2

0.55

1366

8109

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

234

575

4.10

84.05

2.1

2.2

13.6

13.7

0.02

111

251

(3022145) Colonoscopy Study observation

1704

10479

1.71

83.17

1.3

—

(3044889) 12 lead EKG panel

7928

67560

1.46

83.13

4.4

3.6

—

(3029075) Extractable nuclear Ab panel - Serum

139

220

6.34

82.86

1.1

1.0

—

(3025941) Bacteria identified in Stool by Culture

1004

5256

1.98

82.63

1.3

1.2

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

1023

5395

1.96

82.41

1.8

1.6

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

2673

18433

1.56

82.10

4.4

3.5

ng/l

198.1

471.7

4.37

2013

14127

(3030981) Hyaline casts [#/volume] in Urine by Automated count

921

4710

2.02

80.96

3.2

2.6

e6/l

0.2

0.3

4.29

887

4564

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

601

2596

2.37

80.82

1.3

1.2

—

(3002385) Erythrocyte distribution width [Ratio]

9232

81275

1.50

80.34

26.8

15.4

13.9

13.7

47.13

9135

79216

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

344

1126

3.09

79.90

2.3

2.7

u/ml

13090.0

1079.3

0.46

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

14.02

79.40

1.4

1.0

40.3

45.6

0.29

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

174

355

4.92

78.99

1.2

1.1

u/ml

11.0

6.1

0.29

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

190

421

4.54

78.06

1.3

1.2

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

7139

60016

1.43

77.87

3.2

3.0

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

2176

14468

1.60

77.70

2.1

2.0

29.8

29.6

0.71

2115

14045

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

1231

7029

1.82

77.36

1.3

1.2

iu/ml

107.6

150.8

3.39

436

2720

(3016502) Oxygen saturation in Arterial blood

1466

8811

1.74

77.33

7.1

7.0

95.7

95.6

0.13

1411

8484

(40768443) Skin Pathology biopsy report

833

4188

2.05

76.65

1.2

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

209

506

4.16

76.60

2.4

2.7

e9/l

0.2

1.18

184

435

(40768804) Tissue Pathology biopsy report

5243

41796

1.43

76.52

2.3

2.1

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

524

2202

2.42

74.88

1.7

1.5

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

284

870

3.29

73.67

3.1

3.9

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

1212

6988

1.80

73.58

3.1

2.6

ml/min/173m2

64.9

65.2

0.11

549

2771

(3003396) Base excess in Arterial blood by calculation

1611

10060

1.68

73.57

6.8

6.6

mmol/l

1.3

1.1

1.85

1312

7833

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1610

10059

1.68

73.37

6.9

6.6

kpa

5.0

5.1

1.21

1536

9577

(3027801) Oxygen [Partial pressure] in Arterial blood

1607

10054

1.68

72.81

6.9

6.6

kpa

12.1

12.6

2.53

1534

9573

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

1312

7783

1.75

72.18

2.5

2.3

ug/l

6.7

6.9

0.08

1091

6656

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

369

1331

2.81

71.97

1.5

1.4

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

762

3813

2.05

70.90

2.2

1.9

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

265

797

3.35

70.81

2.7

3.4

60.1

57.7

0.87

169

507

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

463

1887

2.49

70.69

1.7

1.6

—

(21494890) Protein electrophoresis panel - 24 hour Urine

263

791

3.35

70.27

1.5

2.2

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

204

518

3.96

70.09

2.5

2.7

e6/l

708.2

732.8

0.14

234

(3045424) Erythrocytes [Presence] in Urine

382

1434

2.70

69.00

1.5

—

(3007461) Platelets [#/volume] in Blood

11665

109585

1.98

68.98

34.9

18.5

e9/l

260.9

254.3

22.58

11506

106021

(3010503) CD19 cells [#/volume] in Blood

192

475

4.06

68.38

2.5

2.7

e9/l

0.3

0.4

0.29

185

462

(3024731) MCV [Entitic volume]

11667

109647

1.98

68.34

34.7

18.4

91.6

91.0

37.25

11573

107581

(3035941) MCH [Entitic mass]

11666

109636

1.97

68.31

34.7

18.4

30.2

0.04

11571

107578

(3010813) Leukocytes [#/volume] in Blood

11669

109675

1.98

68.29

34.9

18.5

e9/l

7.0

6.7

35.10

11483

105739

(3026361) Erythrocytes [#/volume] in Blood

11667

109657

1.97

68.16

34.9

18.5

e12/l

4.4

73.59

11480

105748

(3012544) pH of Venous blood

1398

8577

1.70

67.87

3.9

3.5

7.4

0.81

(3000963) Hemoglobin [Mass/volume] in Blood

11667

109685

1.97

67.68

35.1

18.6

g/l

130.8

133.5

94.16

11573

107632

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

703

3500

2.05

66.23

2.0

1.8

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

188

472

4.00

65.63

1.2

1.1

ratio

1.1

0.73

165

(3002032) Base excess in Venous blood by calculation

1350

8291

1.69

65.14

4.0

3.5

mmol/l

2.2

1.9

1.68

1139

6720

(3014111) Lactate [Moles/volume] in Serum or Plasma

1286

7798

1.71

65.04

6.9

6.3

mmol/l

1.3

0.04

1234

7484

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

306

1057

2.92

64.65

1.5

1.4

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1350

8311

1.69

64.51

4.0

3.5

kpa

5.9

5.8

0.93

1310

8046

(3022313) Gas panel - Capillary blood

720

3654

2.02

64.31

4.2

3.4

—

(3020961) Endomysium IgA Ab [Titer] in Serum

834

4456

1.92

64.16

1.1

titre

196.7

210.9

0.05

118

(3033658) Prothrombin time (PT) actual/Normal

3244

24278

1.44

64.13

4.4

3.7

91.9

91.1

1.00

3152

23635

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

437

1818

2.44

63.79

1.7

1.6

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

331

1207

2.77

63.24

1.1

1.2

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

544

2497

2.22

63.21

1.2

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

501

2237

2.28

62.22

1.3

—

(3017704) Immunofixation for Urine

164

389

4.23

61.81

1.5

1.7

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

1721

11380

1.58

61.51

7.0

6.5

mmol/l

104.3

104.4

0.61

1670

11147

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1317

8165

1.67

61.10

7.6

7.4

g/l

118.1

120.1

3.47

1274

7877

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

390

1572

2.51

60.93

1.3

1.4

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

197

544

3.64

60.06

1.7

1.6

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

388

1587

2.47

58.75

1.2

—

(3019060) Gas panel - Arterial blood

981

5686

1.77

57.94

4.3

4.6

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

452

1995

2.30

57.67

1.4

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1648

10951

1.57

57.34

2.5

2.6

umol/l

6.4

8.3

4.61

1403

9397

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

384

1590

2.44

56.62

1.2

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

305

1139

2.70

55.67

1.5

1.4

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

722

3852

1.91

55.61

1.1

u/ml

1.5

2.4

0.53

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

352

1414

2.52

55.39

1.3

1.2

—

(3022621) pH of Urine by Test strip

1063

6391

1.71

55.05

3.7

2.9

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

275

987

2.81

54.17

1.5

1.4

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

515

2473

2.11

53.30

1.4

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

615

3152

1.99

53.27

4.4

3.6

mmol/l

25.0

24.9

0.17

546

2903

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

144

6.25

53.16

2.4

au/ml

163.2

135.6

0.12

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

358

1482

2.44

52.82

1.2

u/ml

282.1

269.5

0.27

221

942

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

1074

6546

1.69

52.79

2.8

3.4

pmol/l

4.4

4.5

1.80

940

5797

(3014051) Protein [Presence] in Urine by Test strip

467

2170

2.18

52.58

2.4

2.1

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

340

1379

2.49

52.43

1.8

1.7

—

(3009508) Creatinine [Moles/volume] in Urine

3633

28508

1.38

52.40

3.2

3.0

mmol/l

6.9

7.1

1.74

3058

23686

(3000991) Gas panel - Venous blood

1176

7363

1.65

52.09

8.0

7.4

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

10399

96014

1.47

51.89

4.7

4.3

mmol/l

4.6

4.7

17.76

9646

88057

(3008152) Bicarbonate [Moles/volume] in Arterial blood

924

5447

1.74

51.24

6.6

mmol/l

24.9

24.6

1.64

870

5087

(3003327) Ova and parasites identified in Stool by Light microscopy

603

3114

1.97

51.08

1.8

1.7

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

484

2307

2.13

51.06

1.2

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

546

2723

2.04

51.04

1.4

ug/g

297.5

267.3

2.79

304

1557

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

103

195

5.28

51.03

1.6

2.1

u/l

18.9

35.3

1.21

181

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

10001

91747

1.43

50.90

4.2

3.8

mmol/l

1.3

1.2

4.73

9171

83064

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

877

5104

1.76

50.87

2.6

2.4

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

155

5.87

50.48

2.7

3.2

mg/l

7.0

8.2

1.04

127

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

10572

98074

1.48

50.04

5.2

4.8

mmol/l

2.7

2.8

23.66

9785

89486

(3024354) Oxygen [Partial pressure] in Venous blood

1110

6916

1.65

50.03

3.6

3.0

kpa

4.5

0.43

1070

6676

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

122

272

4.49

49.85

2.1

2.2

26.7

29.0

1.05

115

256

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

2309

16894

1.44

49.57

1.6

1.5

—

(3026389) Candida sp identified in Specimen by Organism specific culture

341

1425

2.42

49.28

1.5

1.3

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

341

1425

2.42

49.28

1.2

1.4

u/ml

107.2

115.0

0.56

328

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

101

7.12

48.14

1.6

2.5

mg/l

8.7

9.7

0.62

(3042631) Mycobacterium sp identified in Specimen

298

1183

2.54

48.10

2.9

2.6

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

10299

95224

1.44

48.05

4.6

4.2

mmol/l

1.5

0.17

9512

86891

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

211

702

3.02

47.73

1.2

1.3

titre

—

(40761536) Microorganisms panel - Urine sediment

1261

8206

1.59

47.45

5.7

3.7

—

(3006245) CD3-CD19+ cells/100 cells in Blood

120

277

4.34

46.94

2.1

2.2

9.7

10.7

0.42

111

255

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

143

377

3.80

46.72

2.7

46.2

39.6

1.89

135

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

276

1072

2.59

46.61

1.6

1.5

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

451

2173

2.10

46.24

1.2

1.3

mg/l

615.7

505.2

0.54

424

2057

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

404

1870

2.18

45.92

1.2

1.3

mmol/l

3.7

0.69

370

1757

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

229

824

2.79

44.94

1.7

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

447

2178

2.08

44.49

3.3

2.8

mmol/l

24.8

25.0

0.31

409

1912

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

406

1907

2.15

44.47

1.5

—

(3012516) Albumin [Mass/volume] in Urine

3384

26811

1.35

44.26

3.3

3.1

mg/l

749.9

349.6

3.09

2121

15968

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

157

5.34

42.26

1.1

1.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

519

2721

1.93

42.00

1.2

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

211

754

2.81

41.98

1.8

1.7

—

(42529406) Shigella sp [Presence] in Stool by Culture

520

2729

1.93

41.96

1.2

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1349

9163

1.52

41.58

4.2

3.2

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

514

2701

1.93

41.31

1.2

—

(3000093) Morphology [Interpretation] in Blood Narrative

214

779

2.76

41.12

1.1

—

(3016228) CD19 cells/100 cells in Blood

123

320

3.85

41.00

2.1

2.2

8.5

8.7

0.06

118

312

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

160

497

3.23

40.72

1.1

nmol/l

3.0

8.8

0.83

102

(3020682) Albumin/Creatinine [Ratio] in Urine

3515

28291

1.33

40.54

4.0

3.8

mg/mmol

9.2

8.3

0.47

2205

16962

(3000330) Specific gravity of Urine by Test strip

818

4982

1.68

39.98

4.1

3.5

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

7.48

39.88

1.5

2.1

au/ml

128.5

103.9

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

874

5444

1.64

39.12

8.6

8.2

1.3

1.4

0.37

867

5409

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

282

1205

2.36

38.82

1.1

—

(3023419) Bacteria identified in Sputum by Culture

255

1045

2.45

38.53

2.6

2.7

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

870

5435

1.63

38.47

8.7

8.3

0.7

0.00

862

5401

(3006184) Hemoglobin [Mass/volume] in Capillary blood

407

2023

2.03

38.38

2.3

2.1

g/l

126.9

127.9

0.34

278

1449

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

191

680

2.82

38.30

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

191

680

2.82

38.30

1.7

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

191

680

2.82

38.30

1.7

—

(21494814) CD8 cells/100 lymphocytes in Specimen

118

313

3.77

38.29

2.1

2.2

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

103

248

4.15

38.20

2.1

2.0

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

386

1889

2.06

37.98

1.3

1.4

e6/l

1501.5

3131.5

0.36

311

1546

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

105

260

4.04

37.51

1.2

1.1

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

174

597

2.92

37.35

1.1

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

384

1889

2.05

37.25

1.3

1.4

e6/l

15.3

29.2

0.82

292

1463

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

102

249

4.09

37.15

1.0

1.1

—

(3014007) Fractional oxyhemoglobin in Arterial blood

865

5443

1.62

37.12

8.8

8.4

94.0

0.06

858

5423

(3000060) B lymphocytes [#/volume] in Blood

206

4.41

36.57

2.1

2.2

e6/l

154.4

924.1

1.13

107

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

209

799

2.63

36.53

1.1

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

237

964

2.47

36.41

1.2

u/l

57.2

61.6

0.30

171

643

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

180

639

2.82

36.31

1.2

mg/l

33.9

39.4

1.57

152

522

(1616796) Gas panel - Central venous blood

388

1936

2.02

36.20

3.6

3.3

—

(3052851) Hemolysis interference index of Serum or Plasma

503

2747

1.85

35.89

3.2

3.1

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

175

617

2.84

35.76

1.1

mg/l

224.5

254.8

1.82

149

533

(3028626) Oxygen [Partial pressure] in Capillary blood

383

1914

2.02

35.59

3.3

2.8

kpa

8.2

0.18

364

1784

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

1313

9147

1.48

35.45

2.4

u/l

53.1

43.0

0.26

1107

7755

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

836

5275

1.62

35.44

7.3

6.6

mmol/l

25.1

24.8

1.06

830

5218

(3020876) Protein [Mass/time] in 24 hour Urine

184

670

2.75

35.39

1.7

1.9

g/24h

2.1

1.4

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

685

4109

1.69

35.39

4.1

3.8

mmol/l

24.4

24.2

0.88

609

3706

(3044290) Cell count panel - Cerebral spinal fluid

360

1764

2.06

35.31

1.3

1.4

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

305

1410

2.18

34.82

1.4

1.6

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

105

275

3.82

34.73

1.1

—

(3020891) Body temperature

605

3527

1.74

34.67

4.6

4.5

—

(44790048)

208

823

2.54

33.91

1.5

1.4

—

(44806118)

208

823

2.54

33.91

1.5

1.4

—

(44790047)

208

823

2.54

33.91

1.5

1.4

—

(44790049)

208

823

2.54

33.91

1.5

1.4

—

(4010399)

1002

6662

1.54

33.81

1.5

1.4

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

470

2568

1.85

33.49

2.5

2.4

182.8

190.2

1.03

438

2423

(3003721) Smooth muscle Ab [Units/volume] in Serum

8.01

33.38

1.1

u/ml

2.6

2.7

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

479

2636

1.84

33.35

2.8

2.4

g/l

3.6

0.06

453

2492

(3034426) Prothrombin time (PT)

102

270

3.78

33.25

1.2

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

216

879

2.47

33.19

7.1

6.2

mg/l

12.1

12.2

0.10

197

802

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

254

1114

2.29

32.98

2.6

1.8

mg/l

26.8

26.6

0.02

288

(3001686) Cold agglutinin [Titer] in Serum or Plasma

132

5.14

32.86

1.4

1.2

titre

50.3

201.4

—

(3021901) Oxygen saturation in Capillary blood

329

1602

2.07

32.84

3.1

2.7

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

678

4145

1.66

32.56

4.3

3.7

48.0

48.2

0.07

666

4094

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

338

1671

2.04

32.38

2.7

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

715

4439

1.64

32.31

3.6

3.2

mmol/l

25.5

25.2

1.47

694

4308

(3004119) Hemoglobin [Mass/volume] in Venous blood

844

5483

1.57

31.54

4.0

3.1

g/l

125.5

128.2

3.41

824

5365

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

244

3.85

31.53

2.7

3.2

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

193

769

2.52

31.05

1.1

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

136

452

3.01

30.97

1.3

1.5

ug/l

9.1

8.3

0.09

121

405

(3018405) Lactate [Moles/volume] in Arterial blood

529

3079

1.74

30.47

3.7

3.9

mmol/l

1.3

1.4

0.90

519

3029

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

465

2607

1.80

30.47

1.1

u/ml

4.7

7.8

0.97

344

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

386

2044

1.90

30.33

1.4

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

386

2044

1.90

30.33

1.4

1.3

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

256

3.71

30.22

1.3

1.4

—

(4027681)

140

480

2.92

30.18

1.2

1.3

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

265

1230

2.16

30.00

1.2

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

214

909

2.36

29.95

1.7

1.5

—

(3019174) dRVVT (LA screen)

7.19

29.77

1.3

1.1

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

672

4194

1.63

29.71

3.4

2.6

0.7

1.93

638

4029

(3028433) Virus identified in Specimen by Culture

250

3.72

29.69

1.1

1.2

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

122

394

3.10

29.22

1.4

1.6

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

122

394

3.10

29.22

1.4

1.6

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

680

4278

1.61

29.09

3.4

2.6

1.3

1.2

0.59

675

4251

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

209

899

2.33

28.45

1.1

au/ml

28.5

6.5

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

200

844

2.38

28.43

3.3

3.8

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

275

1332

2.07

27.90

1.1

—

(3000492) Spirometry study

1181

8425

1.43

27.81

1.6

1.4

—

(3001729) Color of Synovial fluid

12.80

27.76

1.7

1.0

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

249

1170

2.14

27.36

1.4

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

130

453

2.87

27.26

1.1

u/l

1.2

1.1

0.57

201

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

248

1166

2.14

27.21

1.4

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

111

354

3.13

27.19

1.2

1.1

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

248

1167

2.13

27.15

1.4

—

(3043409) Potassium [Moles/volume] in Arterial blood

459

2652

1.75

27.15

3.9

4.2

mmol/l

3.8

3.9

0.58

424

2488

(3044009) aPTT.lupus sensitive (LA screen)

6.92

26.84

1.3

1.1

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

253

1206

2.11

26.79

1.4

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

108

342

3.16

26.77

1.7

1.9

umol/l

2.0

1.9

0.55

323

(3025468) Yersinia sp identified in Specimen by Organism specific culture

246

1161

2.13

26.74

1.4

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

712

4623

1.56

26.60

9.2

8.4

mmol/l

24.4

24.3

0.46

658

4299

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

198

857

2.32

26.60

1.2

1.1

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

6.39

26.15

1.1

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

247

1178

2.10

26.13

1.4

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

7.52

26.06

1.1

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

273

1354

2.03

25.99

1.3

nmol/l

0.6

2.2

0.82

261

1298

(3010421) pH of Blood

418

2385

1.77

25.83

4.3

3.6

7.4

0.68

356

1960

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

464

2728

1.72

25.79

2.4

2.1

96.1

91.4

4.67

435

2531

(40767503) Oxygen content in Capillary blood by calculation

351

1905

1.85

25.60

2.9

2.4

15.9

16.2

0.54

198

955

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

180

3.99

25.51

1.3

nmol/l

171.6

119.2

1.33

130

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

177

4.00

25.26

1.2

1.1

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

284

3.30

25.19

1.2

g/l

0.3

1.66

230

(3016018) Differential panel - Cerebral spinal fluid

204

920

2.22

24.88

1.3

1.5

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

6.70

24.78

1.7

1.5

mg/l

1.0

2.6

1.36

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

271

1364

2.00

24.78

1.3

nmol/l

0.1

0.2

1.85

(3012501) Base excess in Blood by calculation

363

2014

1.81

24.67

4.4

3.7

mmol/l

2.7

2.6

0.15

252

1358

(3013290) Carbon dioxide [Partial pressure] in Blood

363

2014

1.81

24.67

4.4

3.7

kpa

5.0

0.04

356

1959

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

254

3.42

24.62

1.2

2.4

u/ml

132457.9

13536.0

—

(3027315) Oxygen [Partial pressure] in Blood

364

2026

1.81

24.48

4.4

3.7

kpa

8.4

8.6

0.98

357

1970

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

481

2897

1.68

24.45

3.0

2.9

u/ml

0.4

0.44

277

1624

(3036489) Thrombin time

554

3468

1.61

24.18

2.2

1.9

21.8

21.5

0.40

479

3029

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

153

619

2.47

23.94

1.4

u/l

13.7

12.5

1.09

145

597

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

271

1387

1.96

23.64

1.1

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

144

572

2.52

23.43

1.2

u/l

87.3

86.4

0.04

126

491

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

161

677

2.38

23.16

1.2

1.3

mmol/l

2.1

0.01

148

631

(3003181) Sodium [Moles/volume] in Urine

317

1726

1.85

22.92

1.5

1.3

mmol/l

60.3

62.3

0.42

263

1356

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

144

579

2.49

22.85

1.3

—

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

6.46

22.76

1.7

1.5

mg/l

1.1

1.5

0.15

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

6.46

22.76

1.7

1.5

mg/l

1.8

2.5

0.38

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

6.46

22.76

1.7

1.5

mg/l

0.8

2.5

1.77

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

6.46

22.76

1.7

1.5

mg/l

2.4

3.5

0.37

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

6.46

22.76

1.7

1.5

mg/l

1.0

1.7

0.65

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

6.46

22.76

1.7

1.5

mg/l

1.9

2.6

0.43

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

6.46

22.76

1.7

1.5

mg/l

3.7

1.4

0.82

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

6.46

22.76

1.7

1.5

mg/l

0.7

0.6

0.15

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

6.46

22.76

1.7

1.5

mg/l

3.5

3.8

0.07

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1565

12063

1.33

22.65

8.7

6.6

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

140

558

2.51

22.64

1.2

u/l

30.0

22.6

0.65

121

472

(3023183) Ammonium ion [Moles/volume] in Plasma

305

1648

1.86

22.60

2.1

2.6

umol/l

30.9

34.3

1.52

253

1374

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1297

9741

1.36

22.30

1.6

1.5

1.4

3.90

1117

8523

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

370

2130

1.75

22.21

3.2

3.0

mg/l

1.6

1.5

3.48

332

1931

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

576

3714

1.57

22.18

1.6

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

142

576

2.47

22.13

1.3

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

173

3.80

21.95

1.5

1.4

ug/l

0.4

0.54

107

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

262

1366

1.92

21.68

1.1

au/ml

14.5

11.1

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

679

4568

1.50

21.51

10.2

9.0

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

246

1261

1.96

21.41

1.3

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

320

2.96

21.28

1.1

ng/l

63.4

1061.3

1.21

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

136

552

2.46

21.19

1.2

1.1

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

153

657

2.33

21.03

1.7

1.5

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

261

3.17

20.92

1.2

118.0

112.9

1.04

239

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

156

678

2.30

20.86

1.1

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

117

446

2.62

20.77

1.1

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

151

649

2.33

20.72

1.1

mg/l

299.3

295.3

0.26

140

585

(3047189) Immunofixation for 24 hour Urine

100

352

2.84

20.70

1.5

1.9

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

107

392

2.73

20.54

2.2

3.3

—

(44806071)

100

4.68

20.52

1.1

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

115

441

2.60

20.19

1.6

1.4

umol/l

21.3

27.6

1.41

109

418

(3011985) Renin [Units/volume] in Plasma

238

1232

1.94

20.15

1.6

1.4

mu/l

47.8

56.4

0.49

210

1092

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

139

584

2.38

20.10

1.6

1.5

u/l

7.8

5.7

0.42

274

(4306422)

244

1275

1.92

20.09

1.2

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

110

414

2.65

20.05

4.1

3.9

—

(3023410) Appearance of Cerebral spinal fluid

182

858

2.12

19.96

1.4

1.6

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

124

496

2.50

19.96

1.6

1.4

—

(21494755) Public health laboratory ask at order entry panel

555

8167

0.66

19.87

1.3

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

107

4.47

19.81

1.2

1.8

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

4.87

19.66

1.0

1.1

—

(3001186) Copper [Moles/volume] in Serum or Plasma

187

3.52

19.63

1.1

1.4

umol/l

18.4

17.0

1.21

167

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

224

1151

1.95

19.40

1.3

pmol/l

288.5

319.9

0.43

170

885

(3013139) Helicobacter pylori Ag [Presence] in Stool

944

6887

1.39

19.34

1.2

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

695

4802

1.46

19.27

1.4

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

157

710

2.21

19.14

1.3

1.2

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

222

1143

1.95

19.12

1.1

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

555

3672

1.52

19.04

4.9

4.6

1.7

1.6

0.32

522

3450

(3035637) Corticotropin [Mass/volume] in Plasma

223

1155

1.93

18.88

1.5

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

224

1168

1.92

18.60

1.0

1.1

g/l

1.5

0.71

206

1054

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

110

432

2.54

18.43

1.6

1.8

137.9

142.5

0.23

110

404

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

413

2575

1.61

18.38

1.7

1.9

iu/l

50.9

7.7

0.72

135

967

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

232

1230

1.89

18.32

1.1

122.5

118.4

0.91

213

1086

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

153

699

2.19

18.21

1.2

1.6

u/ml

18.3

21.5

0.28

157

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

110

435

2.53

18.18

1.7

1.5

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

138

607

2.27

18.01

1.4

1.3

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

296

2.86

18.00

1.0

1.1

96.9

88.8

1.67

127

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

103

4.35

17.99

1.2

1.5

nmol/l

6.4

653093.3

1.52

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

194

3.34

17.88

1.2

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

544

3635

1.51

17.82

5.0

4.7

0.9

0.07

511

3414

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

184

910

2.02

17.81

1.2

1.1

90.8

93.6

0.69

169

845

(3045142) Bone marrow Pathology biopsy report

194

978

1.99

17.79

1.2

1.3

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

109

437

2.49

17.52

2.0

1.9

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

109

437

2.49

17.52

2.0

1.9

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

109

437

2.49

17.52

2.0

1.9

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

109

437

2.49

17.52

2.0

1.9

—

(4034850)

483

3159

1.54

17.49

11.7

8.8

—

(21494434) Karyotype in Bone marrow

154

721

2.14

17.26

1.1

1.2

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

134

594

2.25

17.19

1.4

1.3

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

109

441

2.47

17.19

1.7

1.5

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

299

2.80

17.11

1.0

1.1

113.8

111.6

0.20

273

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

215

3.15

17.06

1.3

—

(3049717) Cytology report of Urine Cyto stain

482

3174

1.53

16.92

2.4

2.7

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

110

451

2.44

16.87

1.1

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

163

790

2.06

16.70

1.4

1.6

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

712

5077

1.42

16.64

1.1

1.0

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

317

2.71

16.41

1.1

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

381

2.54

16.31

2.6

2.4

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

291

2.78

16.24

1.0

1.2

97.1

90.8

0.85

129

(3047181) Lactate [Moles/volume] in Blood

418

2696

1.56

16.14

5.7

5.5

mmol/l

1.3

0.16

369

2386

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

140

651

2.15

16.00

1.3

u/ml

0.2

1.6

3.21

300

(3019768) Coxiella burnetii Ab [Presence] in Serum

6.72

15.97

1.0

1.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

209

3.10

15.88

1.1

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

235

1312

1.79

15.79

1.1

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

105

435

2.41

15.77

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

105

435

2.41

15.77

1.4

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

108

454

2.37

15.71

1.5

1.2

u/l

278.7

307.8

0.12

102

414

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

2219

18632

1.22

15.36

5.2

ug/l

2.3

3.7

5.73

1948

16514

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

198

3.12

15.34

1.1

—

(3048879) Bone marrow aspiration report

219

3.00

15.30

1.4

2.0

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

306

1856

1.65

15.27

3.6

3.2

nmol/l

0.8

0.36

242

1421

(3028271) Lactate [Moles/volume] in Capillary blood

247

1419

1.74

15.07

2.3

1.8

mmol/l

1.7

0.19

242

1377

(3012565) Volume of 24 hour Urine

100

414

2.41

15.07

1.9

2.0

1917.2

1885.2

0.11

363

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

101

4.04

14.95

1.0

1.2

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

174

900

1.93

14.90

1.2

1.6

—

1655.4

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

124

568

2.18

14.76

1.1

iu/ml

11.1

7.9

0.50

145

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

5.88

14.62

1.1

1.0

—

(3015183) Erythrocyte sedimentation rate

403

2.40

14.52

1.7

1.2

—

(3000012) Reticulocyte production index

113

502

2.25

14.50

1.5

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

100

3.98

14.31

1.3

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

118

3.71

14.28

1.5

1.7

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

323

2.56

14.28

2.4

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

152

766

1.98

14.06

2.6

2.8

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1469

11933

1.25

13.72

4.5

33.9

33.1

1.74

1049

7775

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

313

2.55

13.63

1.4

1.3

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

107

479

2.23

13.52

1.6

2.1

106.4

97.5

1.77

100

445

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1107

8727

1.29

13.25

1.9

2.0

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

588

7956

0.72

13.14

1.7

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

337

2.46

13.11

1.8

umol/l

29.1

30.3

0.48

321

(44816559) Phosphatidylethanol [Mass/volume] in Blood

249

1494

1.67

13.02

1.2

1.3

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

102

455

2.24

13.01

1.1

u/l

36.4

23.7

0.67

345

(44813793)

134

666

2.01

12.93

1.2

1.1

—

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

100

444

2.25

12.91

2.4

2.3

u/l

195.1

203.5

0.78

100

438

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

102

458

2.22

12.82

1.1

u/l

91.2

83.9

0.33

356

(3008295) Osmolality of Serum or Plasma

170

920

1.85

12.74

1.4

mosm/kgh2o

276.5

277.9

0.37

129

690

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

227

1339

1.70

12.67

1.1

u/ml

2.9

3.4

0.24

644

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

211

2.83

12.61

1.1

—

(3008536) Aspergillus sp Ab [Presence] in Serum

160

3.11

12.40

1.7

2.0

—

(3004451) EKG impression Narrative

414

2.26

12.39

1.5

1.3

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

208

2.83

12.35

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

214

2.79

12.30

1.1

—

(3005011) Chlamydia sp Ab [Titer] in Serum

3.91

12.27

1.5

1.8

—

(3024869) Neuronal Ab [Presence] in Serum

156

3.13

12.26

1.0

1.1

—

(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence

6.42

12.24

1.0

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

215

2.78

12.19

1.1

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

110

525

2.09

11.89

1.0

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

252

2.61

11.88

1.4

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

448

2.18

11.82

1.3

1.6

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

254

2.59

11.70

1.4

1.3

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

110

529

2.07

11.66

1.0

—

(40768446) Kidney Pathology biopsy report

255

2.58

11.61

1.3

1.5

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

103

484

2.12

11.60

1.0

1.2

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1208

9792

1.25

11.42

2.0

2.1

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

108

520

2.07

11.42

1.3

1.2

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

122

615

1.98

11.37

1.5

2.0

nmol/l

18.0

17.9

0.03

116

586

(3006922) Hepatitis E virus Ab [Presence] in Serum

116

575

2.01

11.34

1.1

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

342

2.33

11.34

2.3

2.1

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

4.01

11.24

1.1

—

(3014271) Vancomycin [Susceptibility]

445

2.15

11.21

3.4

2.8

—

(3009871) Measles virus Ab [Titer] in Serum

248

2.57

11.20

1.6

1.7

—

(3009542) Hematocrit [Volume Fraction] of Blood

9373

89553

1.16

11.19

23.9

13.8

38.7

39.2

5.32

6338

63860

(3017569) Oxygen content in Arterial blood

395

2.22

11.13

2.2

2.1

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

166

2.94

11.06

1.0

1.1

—

(3030313) Adrenal Ab [Titer] in Serum

3.95

11.05

1.1

—

(3032057) Clostridioides difficile [Presence] in Stool

205

2.72

10.97

1.7

1.8

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

350

2366

1.48

10.97

1.2

1.1

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

340

2.29

10.60

2.3

2.1

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

340

2.29

10.60

2.3

2.1

—

(3010838) Calcium [Moles/time] in 24 hour Urine

477

2.07

10.49

1.5

1.7

mmol/24h

5.6

5.7

—

(3028707) Methadone [Presence] in Urine by Screen method

207

1256

1.65

10.46

1.9

2.6

—

(40768441) Liver Pathology biopsy report

124

649

1.91

10.40

1.2

1.3

—

(3016038) Potassium [Moles/volume] in Urine

121

630

1.92

10.31

1.3

1.2

mmol/l

32.3

34.8

0.60

105

536

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

5.38

10.28

1.1

u/ml

0.2

0.1

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

378

2629

1.44

10.25

1.3

1.2

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

2885

25557

1.16

10.23

1.6

mmol/l

1.4

1.3

4.55

2420

21394

(3024928) Oxygen saturation in Venous blood

277

1816

1.53

10.09

4.0

3.1

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

7.10

10.04

1.1

1.0

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

388

5375

0.71

10.02

1.5

1.4

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

103

3.38

9.99

1.1

1.2

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

205

2.62

9.90

1.3

1.1

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

108

552

1.95

9.75

1.1

—

(3019977) pH of Arterial blood

480

2.02

9.60

2.0

2.6

7.4

0.44

173

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

106

3.29

9.57

2.0

1.5

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

111

3.23

9.56

2.8

2.5

mg/l

90.4

55.5

—

(3002256) Pathology report gross observation

1594

13546

1.19

9.36

1.3

—

(3039000) Anion gap in Blood

282

1887

1.50

9.36

6.5

6.4

mmol/l

11.1

11.2

0.30

254

1695

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

217

2.52

9.35

1.3

1.1

—

(3018572) Chloride [Moles/volume] in Blood

282

1888

1.49

9.33

6.5

6.4

mmol/l

104.7

105.1

0.75

254

1696

(3036603) Volume of Urine

113

597

1.89

9.27

1.5

1.7

1782.5

1958.1

0.48

150

(3045716) Anion gap in Serum or Plasma

354

2.17

9.26

2.5

2.2

mmol/l

8.3

9.0

0.90

262

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

348

2.18

9.23

1.9

2.1

umol/l

98.5

147.4

1.43

189

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

104

3.25

9.16

1.0

1.1

u/ml

0.0

0.5

0.89

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

494

3667

1.35

9.15

2.2

2.1

u/l

4902.0

5297.6

0.10

170

1455

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

208

1309

1.59

9.13

1.2

u/l

36.1

35.5

0.02

184

1115

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

4.54

8.95

1.0

u/ml

0.2

0.1

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

216

2.49

8.94

1.1

1.2

—

(3013247) Albumin in CSF/Albumin in Serum or Plasma

154

2.78

8.85

1.0

1.1

mg/g

6.4

0.02

148

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

187

1157

1.61

8.82

1.1

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

4.63

8.72

1.1

1.0

—

(4015189)

225

2.43

8.69

2.6

2.3

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

360

2.10

8.51

1.3

1.2

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

455

1.97

8.45

1.2

1.1

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

171

1048

1.63

8.41

1.4

1.7

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

384

2.05

8.28

1.1

miu/ml

1695.6

1522.9

0.64

384

(3016330) Potassium [Moles/time] in 24 hour Urine

112

3.02

8.14

1.1

1.2

—

91.1

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

229

1516

1.51

8.07

1.4

u/l

26.8

29.7

0.66

199

1263

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

3.98

7.96

1.1

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

3.98

7.96

1.0

1.1

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

104

564

1.84

7.93

1.7

1.5

umol/l

50.3

67.2

—

(3040151) Glucose [Moles/volume] in Capillary blood

172

1072

1.60

7.93

9.5

14.5

mmol/l

7.3

7.5

0.21

148

880

(4035726)

1128

9430

1.21

7.89

1.4

—

(3011288) Drugs identified in Urine by Screen method

279

1932

1.44

7.85

2.3

2.7

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

159

2.63

7.82

1.1

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

122

2.85

7.62

1.3

1.1

—

(3041672) Baker's yeast Ab [Presence] in Serum

5.14

7.37

1.1

1.0

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

100

549

1.82

7.37

1.1

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

512

3951

1.30

7.30

2.0

nmol/l

10.9

11.1

0.20

431

3437

(3044242) Glucose [Moles/volume] in Arterial blood

410

1.94

7.28

2.0

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

323

2.07

7.23

1.4

3.9

mg/l

61.4

563.2

0.51

222

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

166

2.52

7.20

1.1

1.2

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

185

2.42

7.11

1.1

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

100

2.98

7.08

6.3

5.0

ug/min

30.4

45.3

0.85

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

343

4575

0.74

7.08

1.5

—

(3051611) Lipemic interference index of Serum or Plasma

163

1033

1.57

7.05

3.3

3.2

—

(3016244) Insulin [Units/volume] in Serum or Plasma

481

1.84

6.92

2.5

3.3

mu/l

25.7

26.1

0.03

458

(3006270) Folate [Moles/volume] in Blood

142

875

1.62

6.92

1.2

nmol/l

351.7

358.9

0.14

114

715

(4024509)

155

976

1.58

6.91

1.8

1.6

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

160

2435

0.65

6.90

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

159

2422

0.65

6.89

1.4

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

3.12

6.88

1.0

1.1

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

160

2433

0.65

6.88

1.4

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

621

4952

1.26

6.83

1.3

iu/l

30.6

31.0

0.09

542

4279

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

160

2426

0.65

6.79

1.4

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

265

2.14

6.78

1.3

1.2

16.4

20.9

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

308

2234

1.38

6.72

1.3

u/l

13.2

12.6

0.27

257

1831

(40757494) Bilirubin.total [Moles/volume] in Blood

473

1.83

6.66

2.2

2.1

umol/l

14.3

22.8

—

(3011897) Casein IgE Ab [Units/volume] in Serum

115

2.77

6.63

1.1

1.2

u/ml

0.1

5.9

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

299

2164

1.38

6.62

1.8

2.1

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

3.27

6.59

4.0

5.9

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

536

1.77

6.45

1.0

—

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

3.89

6.36

1.0

1.1

u/field

1.2

1.3

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

179

2614

0.68

6.33

1.5

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

124

2.65

6.30

2.4

3.4

—

(36304315) Certolizumab Ab [Units/volume] in Serum or Plasma by Immunoassay

+∞

6.23

1.2

0.0

—

(3002619) Bacteria identified in Specimen by Culture

173

2.36

6.16

1.2

1.3

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1700

14987

1.15

6.16

4.5

20.5

22.3

5.77

831

7760

(3019230) Fractional oxyhemoglobin in Venous blood

212

1465

1.44

6.13

4.5

2.9

60.3

62.6

0.80

212

1458

(3020123) Porphyrins [Interpretation] in Serum or Plasma

3.63

6.12

1.1

1.0

—

(3003338) MCHC [Mass/volume]

8669

83453

1.11

5.99

29.8

16.3

g/l

329.8

331.6

66.28

8616

82686

(3023511) Choriogonadotropin [Units/volume] in Urine

260

1878

1.38

5.87

1.5

1.3

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.96

5.86

1.0

1.1

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

101

2.76

5.79

1.1

1.0

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

3.17

5.78

1.0

1.1

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

737

6104

1.21

5.73

1.9

1.8

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

163

1090

1.49

5.62

1.1

—

(3023199) Leukocytes [#/volume] in Pleural fluid

169

1139

1.48

5.60

1.4

e6/l

2248.8

2560.5

0.16

105

805

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

530

1.71

5.59

1.7

1.9

u/field

1.3

3.1

2.05

360

(43055442) Apixaban [Mass/volume] in Serum or Plasma

115

2.59

5.54

1.4

ug/l

124.3

116.3

0.13

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

308

1.94

5.54

2.9

2.6

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

132

848

1.55

5.49

1.2

1.3

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.91

5.48

1.1

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

190

2.20

5.42

1.0

1.1

95.1

83.6

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

190

2.20

5.42

1.0

1.1

77.5

76.3

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

132

1980

0.66

5.41

1.5

1.4

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

105

2.65

5.40

1.6

1.5

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

137

2039

0.66

5.40

1.5

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

172

2.26

5.35

1.3

1.4

ng/l

84.1

118.8

1.64

172

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

2.79

5.32

2.4

2.2

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

119

754

1.57

5.27

1.4

1.2

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

146

969

1.50

5.25

3.2

5.0

u/ml

96.3

108.3

0.10

281

(3005570) Glucose [Moles/volume] in Urine

161

1092

1.47

5.20

2.4

1.8

—

1.7

—

(36303722) Certolizumab [Mass/volume] in Serum or Plasma by Immunoassay

+∞

5.19

1.0

0.0

mg/l

26.4

—

(3005033) Fetal Nuchal fold Thickness US

133

1973

0.67

5.18

1.4

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

404

3171

1.27

5.16

1.6

mu/l

283.8

307.5

1.41

364

2850

(3050129) First trimester maternal screen panel - Serum or Plasma

223

3015

0.73

5.14

1.4

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

367

1.82

5.11

1.1

1.2

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

2.67

5.08

1.1

1.0

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

154

1041

1.48

5.07

1.4

e6/l

53303.4

52422.7

0.01

601

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

318

1.88

5.07

1.2

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

196

2.13

5.05

1.1

1.4

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

487

1.70

5.01

1.4

1.3

umol/l

4.0

4.8

1.28

455

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

499

0.36

4.97

18.7

11.6

nmol/l

829.3

841.1

0.04

482

(1761482) Bacteria [#/volume] in Urine by Culture

343

2652

1.29

4.95

5.6

4.3

—

(1617658) Protocol used for examination of sentinel lymph nodes

1100

0.57

4.93

1.1

1.0

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

219

1589

1.38

4.89

1.5

1.7

—

(40765096) Chromosome analysis panel by Banding

246

1.98

4.87

1.2

1.1

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

136

2.34

4.81

1.1

1.7

—

(3003434) Protein [Mass/volume] in Pleural fluid

182

1284

1.41

4.80

1.4

g/l

31.6

32.7

0.60

162

1141

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

136

908

1.49

4.79

2.3

2.5

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

4.56

4.73

1.2

1.0

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

138

2.31

4.66

1.3

1.2

ng/l

84.8

751.0

0.59

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

264

1.92

4.66

1.8

2.5

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

264

1.92

4.66

1.8

2.5

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

211

1538

1.37

4.61

1.1

u/ml

5.9

4.8

0.33

105

739

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

576

4764

1.21

4.60

1.8

1.7

—

(3037556) Urate [Mass/volume] in Serum or Plasma

231

1.98

4.59

1.4

—

(3016879) Cocaine [Presence] in Urine

334

2602

1.28

4.58

1.7

2.1

—

(3006576) Bicarbonate [Moles/volume] in Blood

280

1.88

4.56

4.6

6.3

mmol/l

25.1

25.0

0.04

254

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

103

2.51

4.55

2.2

2.0

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

239

1.96

4.53

1.1

1.0

u/ml

0.6

1.5

0.75

118

(3051387) C reactive protein [Mass/volume] in Capillary blood

281

2145

1.31

4.50

5.4

3.3

mg/l

29.2

27.5

0.31

194

1333

(3035082) Kappa light chains [Mass/volume] in Urine

4.73

4.48

1.2

1.0

g/l

0.6

0.1

—

(3050794) Legionella sp Ab [Presence] in Serum

2.84

4.42

1.2

1.1

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

142

2.24

4.39

3.7

2.5

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

101

646

1.56

4.37

1.2

1.3

u/l

14.8

12.0

1.03

597

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

357

1.76

4.35

1.3

1.5

pmol/l

15.6

15.7

0.01

293

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

106

687

1.54

4.33

1.5

1.7

—

(3044416) Complement C4 [Mass/volume] in Pleural fluid

3.69

4.31

1.1

1.2

g/l

0.0

0.1

—

(3010375) cycloSPORINE [Mass/volume] in Blood

300

1.82

4.31

26.2

27.7

ug/l

108.3

116.8

0.48

251

(3027008) Opiates [Presence] in Urine

360

2855

1.26

4.29

1.7

1.8

—

(3028300) Cannabinoids [Presence] in Urine

361

2864

1.26

4.29

1.7

2.0

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

366

1.74

4.29

2.4

2.5

umol/l

51.3

54.7

0.35

312

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

2.71

4.28

3.4

2.7

pmol/l

34.7

49.0

—

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

3.18

4.27

1.1

1.0

u/l

1.7

5.4

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

101

2.46

4.22

1.0

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

2.76

4.22

1.1

iu/ml

14.6

8.5

—

(3012441) Differential panel - Pleural fluid

142

983

1.44

4.21

1.5

1.4

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

156

2157

0.71

4.21

1.4

1.5

—

(3033942) Copper [Moles/time] in 24 hour Urine

3.85

4.20

1.1

1.3

umol/24h

0.3

1.1

—

(3000034) Microalbumin [Mass/volume] in Urine

126

853

1.47

4.20

3.4

2.8

mg/l

60.0

45.9

0.23

603

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

407

1.69

4.15

1.3

1.5

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

3.59

4.15

1.1

—

(3003694) ABO and Rh group [Type] in Blood

2862

26521

1.09

4.15

1.5

1.4

—

(3022689) Creatine [Moles/volume] in Urine

241

1.90

4.10

1.7

1.3

—

(3000764) Benzodiazepines [Presence] in Urine

356

2837

1.25

4.09

1.7

2.0

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

236

1.90

4.01

1.0

1.1

—

(37021550) Renin [Units/volume] in Plasma --upright

181

2.03

4.01

1.1

1.3

mu/l

66.1

71.8

0.11

137

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

3.17

4.00

1.1

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

3.17

4.00

1.1

1.3

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

129

2.24

3.98

1.1

1.0

u/ml

0.1

4.7

0.60

(43055459) Dabigatran [Mass/volume] in Serum or Plasma

3.90

3.93

1.6

1.1

ug/l

113.6

156.8

—

(3035933) Granulocytes/100 leukocytes in Blood

232

1.89

3.87

1.6

1.9

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

261

2018

1.29

3.86

2.5

3.3

u/ml

202.1

556.8

1.24

230

1831

(3008037) Lactate [Moles/volume] in Venous blood

281

2194

1.28

3.85

4.0

3.1

mmol/l

1.5

1.6

0.72

271

2151

(3019832) Treponema pallidum Ab [Presence] in Serum

959

8403

1.14

3.83

1.5

1.7

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

2.75

3.79

1.1

1.2

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

107

2.32

3.76

1.3

1.5

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

404

1.65

3.75

1.6

1.7

nmol/l

2.6

4.7

1.02

336

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

2.46

3.73

1.0

u/ml

0.1

0.42

(3027944) Amphetamines [Presence] in Urine

350

2820

1.24

3.69

1.6

2.0

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.43

3.65

1.0

1.1

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

225

1721

1.30

3.64

1.2

1.1

u/ml

2.1

1.2

0.54

632

(4211845)

502

1.57

3.59

4.2

2.7

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

177

1311

1.35

3.58

1.2

1.1

iu/ml

29.5

8462.6

0.57

292

(3008401) Mugwort IgE Ab [Units/volume] in Serum

196

1474

1.33

3.58

1.1

u/ml

0.3

1.0

2.48

577

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

141

1007

1.40

3.58

1.0

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

2.52

3.57

2.1

2.7

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

122

850

1.43

3.56

1.3

u/l

554.8

425.6

0.34

114

797

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

2.92

3.52

1.1

1.0

—

(40768806) Pleura Pathology biopsy report

142

1019

1.39

3.51

1.4

1.5

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1203

10759

1.12

3.49

3.2

3.1

ug/l

0.7

0.8

3.34

838

7421

(3018001) Oat IgE Ab [Units/volume] in Serum

2.79

3.47

1.0

u/ml

0.3

0.2

—

(4198724)

315

1.71

3.45

1.7

3.1

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

2.59

3.41

1.1

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

128

910

1.40

3.36

1.9

1.7

pmol/l

183.4

183.5

0.01

119

851

(3049242) von Willebrand panel - Platelet poor plasma

3.68

3.31

1.4

1.6

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

426

3546

1.20

3.29

1.5

—

(3023383) Lactate [Moles/volume] in Pleural fluid

269

1.74

3.23

1.3

mmol/l

3.2

3.4

0.11

248

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

120

851

1.40

3.22

2.3

2.1

u/field

1.3

2.6

2.87

318

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

134

970

1.38

3.18

1.3

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

566

1.49

3.17

1.3

mmol/l

5.4

5.8

2.57

538

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

2.56

3.16

1.2

1.1

—

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2.49

3.16

1.2

1.1

nmol/l

18.0

11.6

—

(3038515) Glucose [Moles/volume] in Venous blood

262

2086

1.25

3.13

4.2

3.2

mmol/l

7.0

7.7

5.36

254

2052

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

444

3730

1.19

3.12

2.5

3.4

u/ml

81.5

2323.7

2.20

365

3169

(3042733) HLA Ab [Presence] in Serum

207

1.83

3.09

5.8

4.8

—

(3052592) Norovirus Ag [Presence] in Stool

186

1.87

3.07

1.2

1.3

—

(3016750) Collection duration of Urine

492

1.52

3.02

2.4

2.0

min

516.2

501.1

0.66

368

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

3.22

3.02

1.4

1.8

u/l

0.0

—

(3012989) Citrate [Moles/time] in 24 hour Urine

5.80

3.00

1.3

1.7

mmol/24h

2.1

1.8

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

2.57

2.99

1.1

1.8

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

183

1403

1.30

2.98

1.1

u/ml

1.1

1.7

0.57

341

(3036782) Glucose [Moles/volume] in Pleural fluid

121

872

1.38

2.98

1.3

mmol/l

6.3

6.5

0.32

110

802

(3006462) Nitrate [Presence] in Urine

462

1.53

2.97

4.5

2.8

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

169

1283

1.31

2.96

2.8

2.3

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

2102

19486

1.09

2.96

1.5

1.4

—

(3045788) Cell count panel - Pleural fluid

122

882

1.38

2.95

1.5

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

106

749

1.41

2.93

1.3

nmol/l

1.7

1.4

1.76

674

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

5.35

2.85

1.0

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

476

4064

1.17

2.79

1.5

1.4

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

136

1.97

2.79

1.0

1.2

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

198

1549

1.27

2.79

1.4

nmol/l

0.3

0.4

0.74

152

1185

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

116

2.06

2.77

1.9

1.7

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

160

1219

1.31

2.76

1.7

2.1

umol/l

7.9

6.7

0.22

119

895

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

254

1.68

2.70

1.1

u/ml

9.8

8.1

—

(3051593) INR in Capillary blood by Coagulation assay

457

1.50

2.70

7.8

11.9

—

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

5.96

2.68

1.2

mg/l

1.4

1.9

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

387

1.54

2.65

1.0

1.1

89.8

91.9

0.23

298

(3020874) Milk IgE Ab [Units/volume] in Serum

540

1.46

2.65

1.1

1.0

u/ml

0.3

1.9

1.19

143

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

125

1650

0.75

2.65

1.4

1.5

—

(3051651) Icteric interference index of Serum or Plasma

584

1.43

2.59

2.9

3.5

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

228

1.70

2.56

3.8

7.5

u/ml

75.5

127.8

—

(3042517) Benzodiazepines panel - Urine

2.28

2.53

2.4

2.1

—

(3020618) Glucose [Moles/volume] in Synovial fluid

5.42

2.53

1.3

1.0

mmol/l

6.1

6.5

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

5.42

2.53

1.0

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1227

11197

1.10

2.48

2.9

4.0

ug/l

9.2

23.7

2.89

972

9030

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

149

1143

1.30

2.48

1.7

1.8

ug/l

18.4

24.3

1.72

143

1117

(4281824)

109

1451

0.74

2.47

1.1

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

467

1.47

2.46

1.1

u/ml

9.9

6.5

0.33

(3038177) Helicobacter pylori Ab [Presence] in Serum

204

1629

1.25

2.46

1.3

1.2

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

459

1.47

2.46

1.4

1.5

nmol/l

1.2

0.02

363

(3028717) Thiamine [Mass/volume] in Blood

2.09

2.44

1.2

—

(4146454)

129

973

1.32

2.44

2.4

2.6

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

271

1.61

2.39

1.1

—

(4094501)

297

2473

1.20

2.39

1.1

—

(3007919) Fasciola sp Ab [Titer] in Serum

4.97

2.38

1.0

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

6.21

2.36

1.0

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

2.24

2.30

1.9

2.8

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

221

1.66

2.28

1.1

umol/24h

0.6

0.21

102

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

435

1.46

2.26

1.0

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

307

2579

1.19

2.26

1.9

1.7

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

214

1.67

2.26

1.2

pmol/l

311.4

287.6

0.14

152

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

346

2943

1.17

2.20

1.4

1.3

miu/ml

186.9

229.8

1.47

141

1391

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

120

1.91

2.20

1.1

1.0

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

158

1966

0.80

2.18

1.8

—

(3035880) pH of Pleural fluid

481

1.43

2.15

1.2

1.3

—

(3051339) Copper [Moles/volume] in Blood

2.48

2.15

1.4

1.1

umol/l

15.8

17.0

0.31

(3024316) Viscosity of Plasma

2.48

2.15

1.2

1.6

mpas

1.3

1.6

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

4.26

2.13

1.0

1.1

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

262

2184

1.20

2.12

2.4

2.3

ug/min

102.0

86.8

0.18

154

1256

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

2.35

2.08

1.0

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

355

0.53

2.08

1.6

1.9

e6/l

3491.7

2449.8

—

233

(3011335) Digoxin [Mass/volume] in Serum or Plasma

2.09

2.08

2.1

2.5

—

(1761868) Lipid panel - Serum or Plasma

3225

33394

0.94

2.07

2.9

2.8

—

(3018291) Platelet Ab [Presence] in Serum

4.97

2.06

1.0

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

102

1.95

2.06

1.1

1.2

umol/24h

1.6

0.05

102

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

2.24

2.04

4.6

4.2

—

(3003633) Ovomucoid IgE Ab [Units/volume] in Serum

2.48

1.98

1.0

1.1

u/ml

0.1

6.4

0.53

(3014133) Dog dander IgE Ab [Units/volume] in Serum

153

1218

1.25

1.97

1.1

u/ml

2.7

3.8

0.36

447

(3007463) Buprenorphine [Presence] in Urine

3.31

1.95

2.6

4.0

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

2.94

1.92

1.3

1.1

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

2.34

1.92

1.1

1.0

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

2.71

1.91

2.1

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

169

1366

1.23

1.91

1.7

1.6

nmol/l

39.5

45.5

2.39

162

1320

(3035320) C reactive protein [Mass/volume] in Body fluid

689

1.33

1.90

3.0

2.4

—

(3024471) HLA-A [Type]

233

1.58

1.90

1.0

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

2.10

1.88

1.0

2.3

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

208

1722

1.20

1.86

1.6

1.8

nmol/l

0.8

0.41

180

1431

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

2.63

1.84

1.6

1.4

nmol/l

525.8

394.1

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

166

1.68

1.82

2.0

umol/l

13.9

17.0

1.03

166

(3046904) Somatotropin [Units/volume] in Serum or Plasma

3.51

1.82

1.7

1.1

mu/l

1.6

1.9

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

4.14

1.81

1.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

4.14

1.81

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

4.14

1.81

2.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

4.14

1.81

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

4.14

1.81

2.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

4.14

1.81

2.0

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.94

1.76

3.3

5.5

—

(4133840)

191

1.61

1.76

1.1

1.2

—

(3043410) Blood group antigens tested for on Red Blood Cells

255

1.52

1.73

1.7

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

126

1000

1.25

1.71

1.1

1.0

u/ml

0.1

0.4

1.02

211

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

1.96

1.71

1.0

1.1

—

(40762365) Oxygen content in Arterial blood by calculation

147

1.69

2.4

2.9

ml/dl

15.0

14.8

0.08

140

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

209

1.57

1.68

1.4

27.3

21.0

0.49

173

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

178

1.62

1.68

1.2

mg/l

0.7

48.5

0.94

134

(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum

2.28

1.67

1.0

u/ml

5.4

16.3

0.78

(40768795) Lymph node Pathology biopsy report

129

1030

1.25

1.67

1.4

1.2

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

2.05

1.67

1.0

1.1

u/l

6.5

9.1

0.71

(1002224) Polysomnography panel

382

3353

1.14

1.66

1.1

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

290

1.47

1.66

1.1

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

3.14

1.65

1.8

2.1

—

(40762887) Creatinine [Moles/volume] in Blood

3.14

1.65

1.5

1.3

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

126

1.74

1.64

2.9

2.5

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

2.78

1.63

1.1

1.0

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

119

1.75

1.62

1.3

1.4

nmol/l

0.3

0.20

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

1.96

1.61

1.0

u/ml

0.0

—

(3001019) Free T4 and TSH panel - Serum or Plasma

467

5151

0.90

1.55

1.7

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

121

1.72

1.54

1.2

1.3

33.8

50.1

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

106

837

1.26

1.53

1.3

mmol/l

16.0

11.3

2.03

193

(40757373) Influenza virus identified in Isolate

183

1.58

1.52

1.6

1.5

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

1.84

1.52

19.8

10.8

mmol/l

4.8

5.1

0.38

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

2.09

1.52

1.1

1.0

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

3.31

1.51

1.0

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

2.84

1.49

5.2

5.8

umol/l

274.0

415.3

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

2.84

1.49

1.8

2.2

—

(3046861) Legionella sp Ag [Presence] in Urine

2.35

1.44

1.0

1.1

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

2.35

1.44

1.2

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

2.21

1.44

1.2

1.6

umol/24h

236.1

321.7

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

2.48

1.44

5.9

8.1

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

314

0.60

1.43

1.4

1.7

e6/l

1942.1

13866.1

—

164

(3011648) Oxygen content in Venous blood

652

1.28

1.42

2.1

2.4

10.6

10.9

0.30

652

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

203

1.52

1.41

6.7

5.8

64.8

69.9

0.44

160

(40758292) HTLV I+II Ab panel - Serum

125

1.67

1.40

1.4

1.5

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

139

1145

1.21

1.39

1.1

u/ml

3.6

4.8

0.34

440

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

912

8458

1.08

1.36

1.5

1.4

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

165

1.57

1.36

1.4

1.3

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

2.18

1.36

1.0

1.9

—

(3018834) Bilirubin.total [Presence] in Urine by Test strip

1.99

1.35

2.4

3.6

—

0.0

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

2.92

1.35

1.2

nmol/24h

140.5

91.6

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

1.82

1.32

2.0

1.7

umol/l

39.2

44.7

0.55

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

111

1345

0.82

1.32

1.2

1.4

ug/l

2.5

4.0

2.27

1148

(3009677) Dengue virus Ab [Presence] in Serum

2.41

1.30

1.3

1.2

—

(3020393) Adenovirus Ag [Presence] in Stool

1.77

1.30

1.3

1.1

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

1056

0.80

1.29

1.2

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

208

1.48

1.28

1.8

2.1

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

1.83

1.27

1.0

u/ml

0.0

—

(3044007) Cell count panel - Peritoneal fluid

288

0.62

1.23

1.5

1.7

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

388

1.33

1.21

1.6

1.7

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

203

1.47

1.20

1.3

1.5

—

(3036525) Urea [Moles/time] in 24 hour Urine

2.15

1.20

3.3

3.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

669

1.25

1.20

4.6

6.6

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

1.95

1.19

1.1

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

1.95

1.19

1.1

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

623

0.75

1.19

1.6

1.5

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

2.04

1.14

1.9

1.4

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

157

1.52

1.14

1.2

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

1.79

1.12

1.0

u/ml

0.0

0.6

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

1.71

1.12

1.3

1.2

ug/l

110.6

105.5

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

120

1000

1.19

1.12

1.3

1.2

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

333

1.34

1.12

2.4

3.0

umol/l

28.7

28.3

0.07

249

(3013945) Hepatitis B virus e Ab [Presence] in Serum

1.94

1.07

1.0

1.9

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

2.17

1.07

3.0

—

(3041806) Other cells [#/volume] in Blood by Manual count

276

1.37

1.07

1.8

1.5

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

1.86

0.99

1.0

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

204

1.41

0.99

1.8

2.5

mmol/l

6.9

7.4

0.41

118

(3004775) Volume in Urine collected for unspecified duration

714

1.21

0.98

2.4

2.2

773.1

612.2

2.60

480

(3024932) HLA-DR beta [Type]

230

1.38

0.97

1.1

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

645

0.78

0.96

1.1

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

2.21

0.93

1.3

1.1

nmol/l

365.5

239.9

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

2.21

0.93

1.2

1.0

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

250

1.35

0.92

1.2

1.3

ug/l

371.9

292.0

0.11

146

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

193

1.39

0.87

6.1

7.3

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

161

1.42

0.83

1.0

1.3

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

165

0.60

0.83

1.3

1.2

—

(3020491) Glucose [Moles/volume] in Blood

704

1.19

0.80

1.5

1.8

mmol/l

6.5

6.6

0.16

499

(3004347) Hepatitis D virus Ab [Presence] in Serum

0.00

0.79

0.0

1.0

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

266

1.31

0.79

1.0

—

(3000285) Sodium [Moles/volume] in Blood

130

1.45

0.78

1.4

1.1

—

(3016031) Almond IgE Ab [Units/volume] in Serum

1.71

0.78

1.0

u/ml

0.1

0.6

—

(3033799) Differential panel - Peritoneal fluid

302

0.72

0.77

1.9

1.8

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

139

1.43

0.76

2.3

2.7

u/field

0.6

0.7

0.49

139

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

1.75

0.75

1.2

1.0

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

107

1.49

0.74

1.1

1.3

u/l

2446.1

84.6

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

1.83

0.73

4.9

4.1

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.63

0.73

1.0

1.1

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

1.99

0.72

1.0

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

371

3431

1.08

0.71

1.8

1.6

mg/l

4.8

3.2

1.42

291

2314

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

280

1.28

0.70

1.3

1.5

76.0

72.5

0.98

266

(3020650) Glucose [Presence] in Urine

228

1.31

0.69

1.1

1.4

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

156

1387

1.12

0.69

1.6

1.5

—

(40763791) Oxygen content in Venous blood by calculation

1.84

0.68

9.2

4.8

ml/dl

13.1

12.1

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1133

10836

1.04

0.68

1.7

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

729

6907

1.05

0.66

3.0

3.7

u/ml

38.3

63.3

2.94

705

6666

(3014339) Estrone (E1) [Moles/volume] in Serum or Plasma

1.77

0.65

1.0

pmol/l

448.4

249.4

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

1.77

0.65

1.2

1.0

—

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

153

1.36

0.64

1.7

1.6

mmol/l

1.2

0.16

146

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

153

1.36

0.64

1.0

1.1

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

384

1.22

0.63

1.6

2.9

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.53

0.59

1.3

1.0

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

705

0.86

0.55

1.5

1.6

mmol/l

7.7

7.8

0.16

424

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

273

1.24

0.55

1.3

1.5

mu/l

396.1

437.3

0.19

259

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

1.52

0.54

4.2

2.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

141

1.34

0.54

1.2

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

141

1.34

0.54

1.2

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

141

1.34

0.54

1.2

1.1

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

168

1.30

0.52

5.4

7.4

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

465

0.83

0.51

1.7

1.4

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

213

1.26

0.51

1.1

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

117

1.36

0.50

1.7

3.4

umol/l

42.5

39.0

0.16

101

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

1.44

0.50

1.0

1.1

—

(40768793) Breast Pathology biopsy report

286

3024

0.94

0.49

1.3

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

1.51

0.48

1.0

1.3

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

1.51

0.48

1.0

1.3

—

(3029396) Erythrocyte agglutination [Presence] in Blood

242

0.78

0.46

2.6

2.8

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

638

0.87

0.45

1.0

ng/l

44.3

45.1

0.05

421

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

424

0.84

0.44

1.4

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

635

0.88

0.43

1.0

ng/l

687.1

689.9

0.02

411

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

1.60

0.42

1.0

—

(3022670) pH of Venous cord blood

0.00

0.41

0.0

1.1

—

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

0.00

0.41

0.0

1.0

—

(40769427) Triglyceride [Moles/volume] in Peritoneal fluid

0.00

0.41

0.0

1.1

—

3219.2

—

(40758047) Lysozyme [Mass/volume] in Pleural fluid

1.37

0.40

1.1

1.2

mg/l

5.8

8.8

0.74

(3022475) Manganese [Moles/volume] in Blood

1.42

0.40

1.2

1.3

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

631

0.88

0.40

1.0

ng/l

356.1

332.8

0.28

422

(3020356) Listeria sp identified in Specimen by Organism specific culture

1.32

0.40

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

139

1278

1.08

0.39

1.2

1.1

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

123

1.29

0.38

1.1

1.2

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

159

1.25

0.38

1.2

mmol/l

1.3

1.8

—

103

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

291

3040

0.95

0.37

1.8

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

549

1.12

0.37

1.3

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

144

1331

1.08

0.36

1.3

mmol/l

7.2

7.3

0.24

110

956

(3001893) Eosinophils/100 leukocytes in Pleural fluid

298

1.17

0.35

1.3

1.4

2.1

0.01

262

(3032868) Hemoglobin electrophoresis panel in Blood

0.63

0.35

2.0

1.6

—

(3011325) HIV 1+2 Ab [Presence] in Serum

1.42

0.35

1.2

1.0

—

(3003740) Influenza virus B Ag [Presence] in Specimen

138

1280

1.07

0.33

1.2

1.1

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

1.30

0.32

1.0

1.1

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

479

1.12

0.32

1.1

1.0

u/ml

0.1

0.3

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

136

1.24

0.32

1.0

1.1

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

0.72

0.30

1.6

1.5

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

126

1338

0.93

0.30

3.0

3.8

u/ml

26.1

55.7

4.60

126

1319

(3009466) Valproate [Moles/volume] in Serum or Plasma

136

1266

1.07

0.30

4.1

4.8

umol/l

345.7

364.1

0.83

110

1083

(4212803)

1.28

0.28

1.0

1.1

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

236

0.84

0.28

1.7

1.8

ug/l

1.3

3.4

1.10

139

(3025315) Body weight

1.28

0.28

2.6

4.4

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

353

1.13

0.27

1.2

1.4

65.1

67.8

0.19

302

(3020191) Ethanol [Moles/volume] in Serum or Plasma

593

1.09

0.25

1.7

1.4

promille

1.0

1.3

1.14

443

(3001556) Androgen free Index in Serum or Plasma

1.22

0.25

1.1

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

104

1.24

0.25

1.1

1.0

—

(3034988) Calcium [Moles/volume] in Capillary blood

169

1.18

0.24

1.5

1.7

mmol/l

1.2

0.87

159

(3002331) Protein [Mass/volume] in Peritoneal fluid

200

0.84

0.24

1.4

1.3

g/l

24.6

28.5

0.48

158

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

1.27

0.22

1.0

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

246

1.13

0.22

1.1

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.21

0.0

2.7

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

5.4

—

0.2

—

(3027305) Fractional oxyhemoglobin in Arterial cord blood

0.00

0.20

0.0

1.1

—

38.9

—

(3020093) Fractional oxyhemoglobin in Venous cord blood

0.00

0.20

0.0

1.1

—

70.5

—

(3006598) pH of Arterial cord blood

0.00

0.20

0.0

1.1

—

(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood

0.00

0.20

0.0

1.1

—

7.0

—

(3021706) Oxygen [Partial pressure] in Arterial cord blood

0.00

0.20

0.0

1.1

—

4.0

—

(3003577) Lead [Moles/volume] in Blood

1.22

0.20

1.3

1.2

—

0.1

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

1.19

0.19

1.0

u/ml

0.0

0.5

—

(3039443) Prostate specific Ag panel - Serum or Plasma

863

0.94

0.18

1.6

1.7

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

127

1.17

0.18

1.0

1.1

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

326

1.10

0.18

1.3

pmol/l

70.1

53.3

0.34

110

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

462

1.08

0.17

2.4

2.1

ug/min

80.1

109.8

0.19

111

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

309

2993

1.03

0.16

1.5

1.4

pmol/l

106.9

153.0

2.69

303

2914

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

486

1.06

0.14

1.8

1.9

—

(40768800) Prostate Pathology biopsy report

130

1249

1.03

0.12

1.3

1.2

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

126

0.87

0.12

18.5

6.7

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

133

1.12

0.11

1.3

1.2

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

541

1.05

0.10

1.0

u/ml

1.3

1.7

0.11

120

(3023436) Glucagon [Mass/volume] in Serum or Plasma

1.08

0.08

1.3

1.7

ng/l

191.5

182.2

—

(3010937) Rubella virus Ab [Presence] in Serum

1.06

0.08

1.0

1.1

—

(3014891) Appearance of Pleural fluid

135

1.10

0.08

1.5

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

163

0.91

0.08

1.1

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

1.02

0.07

1.0

1.2

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

127

1.09

0.07

1.1

1.2

mmol/l

0.3

2.1

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

495

0.96

0.06

1.3

1.4

nmol/l

34.7

30.9

0.35

445

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

260

0.95

0.04

2.0

3.2

ng/l

118.3

118.4

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

643

1.02

0.03

1.3

1.8

—

(44806420)

307

0.97

0.02

2.5

2.4

—

(3051101) Glucose [Moles/volume] in Cord blood

176

0.96

0.01

4.4

6.2

—

(3025130) Human papilloma virus identified in Specimen

163

1627

0.99

0.01

1.9

1.7

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

232

1.03

0.01

1.2

1.5

g/l

12.7

13.7

0.18

183

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

471

1.01

0.00

1.1

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

120

0.99

0.00

1.1

1.2

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.05

0.00

1.0

1.1

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

114

1.05

0.00

1.0

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

134

1.04

0.00

4.6

7.3

—

(40765089) Chromosome analysis panel - Blood by G-banded

204

1.02

0.00

1.0

—

(3014171) Thiocyanate [Moles/volume] in Serum or Plasma

0.00

0.0

1.3

—

176.3

—

(3000219) Insulin receptor Ab [Presence] in Serum

0.00

0.0

1.0

—

(40760866) Procollagen type III.N-terminal propeptide [Units/volume] in Serum

0.00

0.0

1.0

—

(3030940) RBC casts [#/area] in Urine by Computer assisted method

0.00

0.0

1.2

—

(3039528) Macrophages/100 leukocytes in Pleural fluid by Manual count

0.00

0.0

3.1

—

29.6

—

(3014178) Parietal cell Ab [Units/volume] in Serum

0.00

0.0

1.2

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

0.0

1.2

—

(3028917) Waxy casts [#/area] in Urine by Computer assisted method

0.00

0.0

1.2

—

(3002853) Influenza virus B Ab [Titer] in Serum

0.00

0.0

1.0

—

(3017509) Phencyclidine [Presence] in Urine

1.00

0.00

1.6

1.3

—

(3008896) Cortisol [Moles/volume] in Urine

0.00

0.0

1.0

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

0.84

0.00

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint OTHER_SYSTCON_FG and mortality.

Females

Parameter	HR [95% CI]	p-value
OTHER_SYSTCON_FG	1.398 [1.29, 1.52]	< 0.001
Birth year	0.99 [0.98, 1.0]	0.016

During the follow-up period (1.1.1998 — 31.12.2019), 12333 out of 49194 females with OTHER_SYSTCON_FG died.

Males

Parameter	HR [95% CI]	p-value
OTHER_SYSTCON_FG	1.311 [1.19, 1.44]	< 0.001
Birth year	0.987 [0.98, 1.0]	0.004

During the follow-up period (1.1.1998 — 31.12.2019), 5309 out of 15535 males with OTHER_SYSTCON_FG died.

Mortality risk

Mortality risk for people of age

years, who have OTHER_SYSTCON_FG.

N-year risk	Females	Males
1	0.094%	0.271%
5	0.662%	1.469%
10	1.792%	3.85%
15	3.41%	7.055%
20	5.948%	11.935%

Relationships between endpoints

↥

Index endpoint: OTHER_SYSTCON_FG – Other systemic involvement of connective tissue (FG)

GWS hits: 8

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Other systemic involvement of connective tissue (FG)

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints